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Abstract 
In bacteria, the expression of genes is tightly controlled, predominantly at the point of 
transcription. This gives the bacterium the ability to adapt to changing environments. 
RNA polymerase (RNAP) is one of the key players in transcription and must first bind to 
a deoxyribonucleic acid (DNA) promoter upstream of a gene to transcribe it. However, 
the ability of RNAP binding is dictated by the core promoter DNA sequence, the presence 
of transcription activator or repressor proteins and numerous other factors that can 
influence the level of gene expression. The strength of promoters has been indirectly 
measured by estimating the fold change in the expression of transcripts or gene 
products. Only a few studies have attempted to directly address the RNAP flux through 
transcription units, and further studies are still required. 
In the current study, the aim was to directly correlate RNAP gene transcription with the 
strength of core promoter elements. To measure the RNAP binding to any DNA segment 
in Escherichia coli in vivo, I employed the direct method of chromatin 
immunoprecipitation (ChIP), followed by quantification of immunoprecipitated DNA. 
For promoter regions, this method directly measures the occupancy by RNAP; for 
regions within transcription units, the flux of the RNAP was deduced. This method was 
validated using a hierarchy of semi-synthetic promoters inserted in a pRW50 plasmid 
and a chromosomal transcription unit (i.e., the lac operon).   
A range of semisynthetic promoters, with different combinations of core promoter 
elements to obtain different levels of expression, was used in this study. This direct 
method enabled the calculation of “promoter competitivity”, “promoter occupancy 
index” (POI), RNAP “escape index” (EI), “fragment occupancy percentage” (FOP) and the 
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time interval between transcribing RNAPs (Tint). On the basis of time intervals between 
RNAPs during transcription, I have been able to calculate the number of RNAPs crossing 
any DNA sequence of interest per second (polymerase per second; PoPS). Surprisingly, 
the results of the present study revealed that the RNAPs are well separated during 
transcription of the lac operon. 
This study has increased our knowledge about RNAP recruitment, escape and flux 
through a transcription unit. The results of this study have implications for synthetic 
biology systems, where precise amounts of gene expression can be tailored to fit a 
particular application. 
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2 
1. Introduction 
1.1. Deoxyribonucleic acid  
Deoxyribonucleic acid (DNA) is the molecular component present in all living cells that 
carries all the genetic information required for the metabolism, growth and 
reproduction of organisms. Friedrich Miescher, a Swiss physician who was studying 
leucocyte proteins in attempt to discover the so-called “building blocks of life”, first 
noticed and isolated this very important molecule inside cells’ nuclei in 1869. He 
investigated the molecule and found that it had specific properties differentiating it from 
cellular proteins. After his discovery, he called this fundamental material “nuclein” 
(Dahm, 2005). Several decades later, it was shown that genes and chromosomes 
carrying genetic information were made up of DNA (Avery et al., 1944). Years later, in 
1953, Watson and Crick first proposed the double-helical structure of DNA, claiming that 
it consisted of two anti-parallel helical chains coiled around the same axis. Watson and 
Crick also published detailed information about the key structural features of DNA 
(Watson and Crick, 1953). This information was proven correct by subsequent research 
on DNA structure. DNA, as it is currently understood, is a double-stranded molecule in 
which two strands are intertwined to form a double-helix. Each DNA strand is a 
polynucleotide, meaning that it composed of a chain of nucleotides linked one to another 
by phosphodiester bonds. Each nucleotide contains 3 constituents: a phosphate group, a 
five-carbon sugar and one of four possible nitrogenous bases: adenine (A), thymine (T), 
guanine (G) or cytosine (C). The phosphate group is attached to the 5’ carbon of the 
sugar molecule and to the 3’ carbon of the next sugar molecule. These connections are 
used to describe the direction of the DNA strand (i.e., 5’3’ or 3’5’). Therefore, 
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phosphate groups and sugar molecules comprise the backbone of the DNA strand. On 
the inner side of the DNA strand, one of the four possible nitrogenous bases is attached 
to the 1’ carbon of the sugar. The rationale for the “deoxyribose” name of the sugar 
molecule is based on a missing hydroxyl group at its 2’ carbon. Adenine and guanine 
nitrogenous bases are known as purines and are characterized by their double-ring 
structure. Cytosine and thymine are categorized as pyrimidines and are characterized by 
their single-ring structure. These bases link the two DNA strands by binding to each 
other through non-covalent hydrogen bonds. Adenine in one DNA strand typically binds 
to thymine on the other strand via two hydrogen bonds, and guanine binds to cytosine 
on the opposite strand via three hydrogen bonds. As the two DNA strands are coiled 
around the same axis, this coiling forms two alternating spaces repeated along the DNA 
called major and minor grooves. 
The significance of DNA is derived from its ability to store the genetic information that 
directs virtually all cells’ activities (Avery et al., 1944). These sequences are transcribed 
into ribonucleic acid (RNA) with the help of a specific cellular protein called RNA 
polymerase (RNAP). Although it is often assumed that all produced RNAs encode for 
proteins, most of these RNAs are non-coding and hence do not code for proteins 
(Mattick and Makunin, 2006). For example, in average growing E. coli, less than 20% of 
produced RNAs code for proteins (Browning and Busby, 2016). There are several types 
of non-coding RNAs (ncRNAs), such as, ribosomal RNA (rRNA), transfer RNA (tRNA) and 
small non-coding RNA (SncRNA) or small RNA (sRNA), which measure approximately 
50 to 300 nucleotides in length (Storz et al., 2011). However, it has been found that 
these non-coding RNAs are of a great importance to bacterial cells. For instance, the 6S 
RNA interacts with RNAP during stationary phase (Browning and Busby, 2016). These 
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sRNAs can also regulate messenger RNAs (mRNAs) and their translation by different 
mechanisms, such as base-pairing with mRNAs and protein activity modulation (Waters 
and Storz, 2009).  
To get the full benefit of DNA, bacterial cells have evolved perfectly to express it. DNA 
expression is the process in which DNA is transcribed to produce different RNAs, 
including the coding mRNAs that are translated by cellular ribosomes to produce 
proteins. 
 
1.2. Bacteria 
Bacteria are unicellular microorganisms that are found everywhere on earth. A myriad 
of different bacterial species have been identified. These bacterial species can be 
classified depending on their different characteristics, such as morphology, life-style and 
their ecological niche (Cohan, 2001). Interestingly, many bacterial species live inside 
and on the surface of other organisms, including mammals such as humans. In humans, 
bacteria can be found on the skin surface and in the mucosa and digestive tract 
(Dethlefsen et al., 2006). Specifically in the gastrointestinal tract, the number of bacteria 
is normally greater than that of human cells (Savage, 1977; Hooper and Gordon, 2001). 
In fact, approximately 500 to 1000 bacterial species colonize the human intestines, with 
bacterial genes estimated to outnumber human genes by an order of 50 to 100 (Hooper 
and Gordon, 2001). The presence of this bacterial flora on the inner intestinal surface is 
essential for human health. The bacteria are critical for the development of the immune 
system in the gut during the very early stages of human life (Chung et al., 2012) and play 
a role in protecting the host against pathogenic bacteria; this protection is improved 
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when two or three species colonize the same area rather than one single species (Dillon 
et al., 2005). Moreover, the composition of these bacterial species inside human gut has 
been found to differ greatly between obese and non-obese individuals, illustrating the 
relationship between host health and normal bacterial flora (DiBaise et al., 2008). Some 
of these bacteria can essentially produce “antibiotics” against other bacteria. These 
antibiotics can be used medically to protect against bacterial infections (Sykes et al., 
1981). In addition to the advantages of normal intestinal flora in terms of protection 
against pathogens, the bacteria can also assist in digestion and human intestinal 
epithelial cell proliferation (Dethlefsen et al., 2006). All of these benefits elucidate the 
intricate bacteria-host relationship and illustrate why it is medically relevant to study 
bacteria and bacterial systems in particular. 
Among bacterial species, Escherichia coli has been extensively studied. The species was 
first isolated in 1885 from a child’s feces by an Austrian pediatrician named Theodor 
Escherich who initially named it Bacterium coli communis; the bacterial species was 
eventually named after him (Welch, 2006; Daegelen et al., 2009). E. coli has been used as 
a model organism since the 1950s. During that era, Francois Jacob, Jacques Monod and 
several other researchers used the organism to expound on the fundamentals of 
molecular biology by studying different aspects of bacterial molecular activities and the 
regulation of gene activity (Jacob and Monod, 1961). Many different E. coli strains have 
then been discovered; however, E. coli K-12 remains one of the most extensively studied 
(Riley et al., 2006). This strain was first isolated in 1922 from the stool of a convalescent 
diphtheria patient (Daegelen et al., 2009). 
Although there are many E. coli strains that are harmless and normal commensal 
inhabitants of mammalian, including humans, intestines, there are a number of 
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pathogenic E. coli strains. Pathogenic strains include enteropathogenic E. coli (EPEC), 
enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), diffusely adherent E. coli 
(DAEC), enteroaggregative E. coli (EAEC) and enterohaemorrhagic E. coli (EHEC). These 
strains are found to cause three different diseases: urinary tract infection, 
sepsis/meningitis and diarrhoea (Kaper et al., 2004). 
The rationale for studying E. coli lies in the fact that the species is native to the human 
gastrointestinal tract and also capable of causing serious infections. Furthermore, E. coli 
are maintainable in clinical laboratories and some strains can multiply in a broad range 
of temperatures ranging from approximately 8°C to 48°C. In addition, the means by 
which basic cellular functions are achieved in E. coli is very similar to that of human cells 
with respect to the storage of genetic information and protein synthesis, however there 
are clearly differences, such as, complexity of RNAP and ribosomes (Berg, 2008). 
 
1.3. Gene expression 
1.3.1. DNA-dependent RNA polymerase 
DNA-dependent RNA polymerase (RNAP) is the key enzyme of bacterial transcription, 
which is the process of copying DNA sequences into RNA sequences. RNAP is a 
multisubunit enzyme that consists of different subunits assembled in a specific way to 
allow RNAP to achieve its role in DNA transcription. In E. coli, RNAP can be found in two 
different forms: the core enzyme and the holoenzyme. The core enzyme is composed of 
five subunits: α2, β, β′ and ω. These subunits are highly conserved in sequence, 
assembly and function among prokaryotes and eukaryotes, including humans (Allison 
et.al, 1985; Archambault and Friesen, 1993). β and β′ are the largest RNAP subunits and 
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are structured in a way that resembles a crab claw, with the subunits assuming the form 
of the respective “pincers”. The location of these two subunits is fundamental for their 
function as they surround RNAP active site cleft (Geszvain and Landick, 2005; 
Mukhopadhyay et al., 2008). One pincer of this claw, which is represented by the β′ 
subunit, has the ability of moving to open and close the claw. β subunit domains 2 and 3 
represent the other pincer of the claw (Cramer, 2002; Geszvain and Landick, 2005; 
Chakraborty et al., 2012). 
Each RNAP α subunit consists of two domains that play distinct role in transcription: the 
C-terminal domain (αCTD) and the N-terminal domain (αNTD). These two domains are 
connected by a linker whose flexibility permits variations in αCTD binding sites and 
permits diverse promoter architectures (Blatter et al., 1994). The main role of the αNTD 
is to assemble the β and β′ subunits together, while the main function of the αCTD is to 
bind to the upstream promoter (UP) element, assisting in promoter recognition and 
binding. The ω subunit plays a role in promoting RNAP assembly and assists in β′ 
subunit folding (Minakhin et al., 2001). In addition to these two roles, the ω subunit 
affects transcription regulation. RNAPs lacking an ω subunit have been found to be 
unresponsive to guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate 
(pppGpp) in vitro. ppGpp is a global regulator during stringent response, which is a 
cellular response to amino acid starvation. However, RNAPs lacking an ω subunit have 
also been found to demonstrate stringent response in vivo as a result of the DksA (a 
transcription factor) protein effect (Vrentas et al., 2005). 
The RNAP core enzyme alone lacks the ability to initiate specific transcription from 
specific promoters. To initiate specific transcription, RNAP needs to bind to a specific 
transcription initiation factor, called the sigma (σ) factor, prior to transcription 
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initiation to form the holoenzyme. (Darst, 2001; Feklistov et al., 2014). Without this 
binding, specific transcription is not possible, as the σ factor plays a fundamental role in 
promoter recognition, positioning of RNAP on DNA and unwinding of the double helix 
DNA at the transcription start site. 
In general, RNAP has a dynamic structure. This means that all of the subunits can move 
slightly within the complex throughout the different transcription steps. This dynamic 
movement clearly explains how the β′ subunit clamps down after the detachment of the 
σ factor during the elongation step (Chakraborty et al., 2012). 
 
1.3.2. Promoter elements 
Promoters are DNA sequences located just before the transcription start site of any 
transcription unit. To clearly understand how the transcription process starts, it is 
important to be familiar with the promoter structure and the role of each promoter 
element in the transcription process. Each promoter has four different regions that are 
mostly conserved among all bacterial species. These regions are known as the -10, 
extended -10, -35 and UP elements, which play a fundamental role in transcription as 
they are responsible for recognizing and recruiting RNAP to transcribe following genes. 
The -10 and -35 elements are the most important promoter elements in transcription. 
The -10 hexamer is located 10 base pairs (bp) upstream of the transcription start site 
and normally starts from base -12 to base -7, with the consensus sequence of 
5’ TATAAT 3’ with three highly conserved bases (T-12 A-11 and T-7) (Shultzaberger et al., 
2007). The -35 hexamer is located 35 bp in the same direction of the -10 hexamer and 
starts from base -30 to base -35 with a consensus sequence of 5’ TTGACA 3’. The 
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extended -10 element starts from base -14 to base -17 and the optimal sequence is TRTG 
(where R is A or G). The UP element is located upstream of the -35 element in an AT-rich 
region participating in recognizing a specific unit of RNAP. These elements are found to 
control promoter affinity to RNAP, and when their sequences are in consensus, 
promoter recognition is optimal (Phan et al., 2012) (Figure 1). 
In addition to these promoter elements, there are two other elements both located 
downstream of the -10 element that play a significant role in the transcription initiation 
process. These elements are the discriminator region and the core recognition element 
(CRE). The discriminator region is located directly downstream of the -10 element from 
base -6 to base -4, and the CRE element is located downstream of the discriminator 
region from base -4 to base +2 (Feklistov, 2013). 
With respect to recognition by RNAP, the -10, extended -10 and -35 elements are 
recognized by three domains of the RNAP σ factor, whereas the UP element is 
recognized by the αCTD domain of RNAP (Figure 2) (Browning and Busby, 2004). 
 
1.4. The transcription cycle 
DNA transcription is the first step of gene expression, where RNAP transcribes a target 
DNA fragment producing a complementary chain of RNA (Suzuki, 2015). One type of 
these newly synthesized RNAs is mRNA, which encodes for protein synthesis by 
bacterial ribosomes (Cukras and Green, 2005). There are three main steps in the 
bacterial transcription cycle: transcription initiation, elongation and termination (Figure 
3). Each step can be divided into several additional steps. 
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Figure 1. Promoter elements. 
This figure illustrates the main promoter elements and their consensus sequences. 
These elements play an important role in RNA polymerase binding.  
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Figure 2. Promoter recognition by RNAP.  
This figure shows the different promoter elements and their recognition by RNA 
polymerase subunits. Adapted from (Browning and Busby, 2004). 
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Figure 3. Transcription cycle steps. 
This figure shows the three main steps of the bacterial transcription cycle: transcription 
initiation, elongation and termination. 
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1.4.1. Transcription initiation 
The transcription initiation step is composed of three different steps: promoter 
recognition and open complex (RPo) formation, transcript initiation and scrunching; 
and promoter clearance. Prior to the promoter recognition step, core RNAP must bind to 
the factor to form the holoenzyme.  
In E. coli, most σ factors belong to the housekeeping σ70 family (Paget and Helmann, 
2003; Feklistov et al., 2014). σ70 factor is known as a housekeeping factor because it is 
responsible for the transcription of most of the bacterial genes during exponential 
growth of the bacteria (Feklistov et al., 2014). Approximately 1643 binding sites for σ70 
factor alone have been recognized in the entire E. coli genome (Cho et al., 2014). 
However, σ70 is not the only σ factor in E. coli. The E. coli genome encodes 6 other 
alternative σ factors to activate transcription of specific genes when the bacterial cell is 
under stress or growing in strict environmental conditions (Paget and Helmann, 2003; 
Gruber and Gross, 2003; Wade et al., 2006). One of these alternative σ factors is σ54, 
which is responsible for directing RNAPs to genes involved in nitrogen starvation and 
other functions (Brown et al., 2014). There are many other σ54-dependent genes. Many 
of the final products of these genes frequently participate in cellular nitrogen 
adjustment (Reitzer and Schneider, 2001). Unlike σ70, σ54 recognizes promoters 
having -12 and -24 instead of -10 and -35 conserved regions. In addition, σ54 does not 
have domain 2, which induces the open complex formation and then positions the 
template DNA strand in RNAP active site (Cook and Ussery, 2013). Thus, σ54 needs a 
transcription factor called an enhancer binding protein for transcription to go forward. 
This alternative σ factor was reported to have around 180 binding sites within the 
whole E. coli genome (Cho et al., 2014). 
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The σ factors, related to the σ70 family, have four different conserved domains (1, 2, 3 
and 4). Each conserved domain has conserved sub-domains. Domain 1 has two 
sub-domains (1.1 and 1.2), domain 2 has four sub-domains (2.1, 2.2, 2.3 and 2.4), 
domain 3 has three sub-domains (3.0, 3.1 and 3.2), and domain 4 has two sub-domains 
(4.1 and 4.2). Among these four domains, domains 1 and 2 has the greatest interaction 
with the coiled coil motif of the ’ subunit of core RNAP. The other two domains have 
only a few polar interactions with core RNAP (Vassylyev et al., 2002; Feklistov and 
Darst, 2011). 
As σ70 is the recognition subunit of the holoenzyme, it needs to contact specific 
promoter elements on the DNA to lead RNAP to the target promoter. The 4.2 conserved 
region of domain 4 of σ70 factor recognizes the conserved -35 promoter element. The σ70 
sub-domains 2.1, 2.3 – 2.4 and 2.4 – 3.0 are inserted into the DNA major groove and 
assist in the recognition of the -10 element. The promoter-extended -10 element is 
recognized by domain 3 of the σ70 subunit (Fenton et al., 2000; Vassylyev et al., 2002; 
Busby and Savery, 2007; Taliaferro et al., 2012). As mentioned previously, before 
making contact with promoters, σ70 must first dock to core RNAP. It has been 
determined that σ70 factor initially contacts three specific regions of the core RNAP β 
and β’ subunits. These contact regions are the β flap region, the β’ coiled coil region and 
a β region located between amino acids 1060 and 1240. These three regions contact the 
σ70 sub-domains 1.1, 2.1 – 2.2 and 3.1, respectively (Burgess and Anthony, 2001). 
It has been shown that UP, -35 and extended -10 elements are initially recognized when 
the DNA is still double stranded (dsDNA). This recognition leads to the formation of the 
closed complex (RPc). Afterwards, Upstream DNA is wrapped on RNAP and downstream 
bases -10 to +20 are inserted into the RNAP active site (Ruff et al., 2015). Then, RNAP in 
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association with σ factor unwinds around 12 to 13 bp of the DNA to form what is known 
as the “transcription bubble” or “open complex”, where the +1 base is positioned in the 
RNAP active site (Gries et al., 2010; Zhang et al., 2012). The -10 element and 
discriminator region are recognized at this point when the DNA is single-stranded 
(ssDNA) (Feklistov, 2013). This recognition starts when the two conserved bases of 
the -10 element (-11 and -7) are flipped out of the ssDNA and inserted into specific 
pockets in the  subunit of RNAP (Feklistov and Darst, 2011). Then, RNAP starts the 
transcription process by synthesizing short non-productive transcripts until the factor 
detaches from the holoenzyme (Vassylyev et al., 2002). By this time, RNAP is tightly 
bound to the DNA and capable of escaping the promoter and proceeding to the 
elongation process. 
 
1.4.2. Transcription elongation 
Transcription elongation is the next step in the transcription process. This step derives 
its importance from being the productive step of transcription as it is responsible for the 
production of RNA, the target of any successful transcription. The transcription 
elongation step can be primarily divided into three main stages: promoter clearance 
(escape), promoter-proximal pausing and constructive elongation. RNAP undergoes 
several conformational changes during transition from the initiation complex to the 
elongation complex (EC), which takes place after the synthesis of 13- to 15-nucleotide 
long RNA fragments, with 7 to 9 nucleotides out of these 13 to 15 nucleotides 
participating in an RNA/DNA hybrid. However, these conformational changes do not 
extremely alter the structure of the core enzyme, as all of the structures needed for RNA 
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synthesis already exist (Saunders et al., 2006; Vassylyev et al., 2002). Nevertheless, 
some of these structures, such as the RNA exit channel, the downstream DNA binding 
site and the RNA/DNA hybrid binding site are in contact with the σ factor of the 
holoenzyme. Thus, RNAP needs to release its σ factor and close its clamp on the DNA 
strand so it can engage itself in a more stable complex to carry out transcription 
elongation (Nudler, 1999). 
After σ factor detachment from RNAP and the escape of RNAP from the promoter, RNAP, 
template DNA and the newly synthesized mRNA form the EC. This EC shows no 
particular affinity to any part of the template DNA and travels along the DNA strand in a 
slide-like movement (Nudler, 1999). Two previous studies analyzed transcription 
elongation rate in vivo and found that for genes producing mRNA, such as the lacZ gene, 
the average transcription elongation rate is 30 to 50 nucleotides per second (Murakawa 
et al., 1991; Vogel and Jensen, 1997). This finding was confirmed in vitro using 
single-molecule studies on RNAP (Larson et al., 2011). The implication of this speed is 
that the ribosomes can catch up with the elongation complex reducing the amount of 
naked RNA (McGary and Nudler, 2013). However, this rate is increased to 
approximately 80 nucleotides per second when transcribing ribosomal operons, such as 
the rrn operon, or producing ribosomal RNA (rRNA) messages that will not be 
translated (Vogel and Jensen, 1994; Condon et al., 1995; Voulgaris et al., 1999). 
During transcription elongation, the EC does not move smoothly or at constant speed 
along the DNA. Instead, the EC may encounter several phenomena that can disturb 
elongation regularity. These events include transcriptional pauses, transcriptional 
arrests and transcript termination. In transcriptional pauses, RNAP rests for a short 
period of time without synthesizing RNA and then continues its process normally. In 
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transcriptional arrests, the same phenomenon occurs, but the enzyme cannot continue 
transcribing without the help of other factors. These events may occur as a result of 
some proteins bound to the DNA that obstruct the path of RNAP (Uptain et al., 1997). 
Overall, in transcriptional pauses and arrests, RNAP molecules stop synthesizing RNA 
transcripts but do not release them and are still able to continue producing RNA. 
Conversely, in transcript termination, RNAP stops synthesizing RNA and releases the 
synthesized transcript and therefore cannot resume synthesizing RNA (Kerppola and 
Kane, 1991). 
In addition, the EC occasionally stops transcribing and moves backwards on the DNA, 
changing the last added base or bases in the nascent RNA chain to ensure that there are 
no mistakes in the nascent RNA sequence. This mechanism is known as backtracking 
and is critical for transcription, as the correctness of the newly synthesized RNA 
sequence is vitally important for all bacterial biological processes (Voliotis et al., 2009). 
Backtracking is characterized by two main steps: diffusion of the EC backwards on the 
DNA and the extrusion of the 3’ end bases of the nascent RNA strand (Sahoo and 
Klumpp, 2013). Backtracking usually takes place after long RNAP halts. One study has 
suggested a role for these long pauses in backtracking by looking at similarities between 
the rate of ribonucleotide misincorporation and the frequency of these long pauses 
(Shaevitz et al., 2003). During backtracking, the 3’ end of the nascent RNA strand 
detaches from the stalled RNAP active site and the EC moves backwards. At this time, 
the 3’ end of the RNA strand can be internally cleaved by some elongation factors, such 
as GreA or GreB factors, to relieve the pause. Then, the cleaved RNA fragment detaches 
from the EC and the EC carries on transcribing downstream DNA by adding the right 
bases to the 3’ end of the RNA transcript (Komissarova and Kashlev, 1997; Poteete, 
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2011).  Promoter–proximal pauses constitute a large proportion of backtracking 
occurrences. These pauses take place at the beginning of the elongation step when the 
EC is close to the promoter (Adelman and Lis, 2012). This area of the DNA is susceptible 
to this kind of pausing as a result of three main reasons. First, the nascent RNA strand is 
still short and unable to form a structure that prevents the EC from moving backwards. 
Second, the robust contact of the promoter elements with the initiation factors and the 
EC may hold the EC back. Finally, there are still no ribosomes and other ECs following 
the paused EC in this region; these tailing ribosomes and ECs usually prevent the 
backward movement by physically pushing the stalled EC (Nudler, 2012). 
Transcription elongation factors, such as NusA, NusB, NusE and NusG, play a significant 
role in the transcription process. The NusA factor is a protein that consists of six 
domains with a total atomic mass of approximately 55 kDa in E. coli (Burmann and 
Rosch, 2011). These domains are composed of the following: the amino-terminal 
domain (NTD), S1, KH1, KH2, acidic repeat1 (AR1) and acidic repeat2 (AR2). The NTD 
exerts its effect by interacting with RNAP at the nascent RNA exit channel, leading to a 
transcriptional pause that may eventually result in termination (Ha et al., 2010). The 
NusA domains S1, KH1 and KH2 represent the newly synthesized RNA chain binding 
domains (Prasch et al., 2009). While the AR1 domain function is not very clear in vitro or 
in vivo, AR2 has been found to play two different roles in transcription. The first role is 
preventing the three RNA binding domains from binding to the nascent RNA strand by 
covering them. The second role is to interfere with the RNAP CTD subunit and prevent 
it from binding to the promoter’s UP element (Mah et al., 2000; Schweimer et al., 2011). 
This transcription elongation factor has been shown to negatively affect transcription 
elongation by increasing the energy needed for EC forward translocation (Mooney et al., 
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2009). Nus factors have a special significance in transcription units that are reliant on a 
dedicated anti-terminator, such as the case for phage lambda (, where the N protein 
exploits the host Nus factors to stabilize the anti-termination complex and ensure full 
read-through as illustrated in Figure 4. 
NusB is a small (15.7 kDa) and often supplementary protein that frequently acts by 
joining other factors to achieve its function (Burmann and Rosch, 2011). NusB consists 
of seven helices, 1 to 7, arranged in two subdomains: the N-terminal ( and C-
terminal () subdomains (Altieri et al., 2000). NusB on its own has the ability to 
bind to an RNA motif containing anti-termination signals called BoxA. It can also bind to 
another Nus factor called NusE to form a heterodimer that have the ability to act as an 
anti-terminator in ribosomal RNA operons (rrn) containing the BoxA motifs (Burmann et 
al., 2009). Furthermore, NusB can interact with the S10 protein of the 30s ribosomal 
subunit, forming a complex that can bind to BoxA on RNA strands and act as an anti-
terminator body (Luo et al., 2008). 
NusE is slightly smaller than the NusB protein with an atomic mass of approximately 
11.7 kDa. NusE is the active member of the NusE–NusB complex, and NusB guides NusE 
to the EC (Burmann and Rosch, 2011). The high similarity of NusE to the S10 protein, a 
30S ribosomal protein, allows it to bind to NusB in a manner identical to the NusB–S10 
complex and bind to the BoxA motif (Luo et al., 2008; Burmann et al., 2009). 
NusG is another transcription factor that consists of two domains, the NTD and the CTD, 
linked to one another by a flexible linker (Burmann et al., 2011). The size of these two 
domains and the linker is approximately 20.5 kDa (Burmann and Rosch, 2011). The NTD 
domain of this transcription factor believed to make a direct surface interaction with 
RNAP (Belogurov et al., 2009). 
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Figure 4. Bacterial phage lambda N protein cooperation with Nus factors. 
This diagram illustrates how lambda N protein cooperates with the host Nus factors to 
ensure full-length transcript. Adapted from (Nudler and Gottesman, 2002). 
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NusG is one of the key protein factors during the transcriptional process due to its 
positive effect on RNAP. This factor reduces transcriptional pause events and increases 
the RNAP elongation rate by promoting its forward translocation (Herbert et al., 2010; 
Burmann and Rosch, 2011). It was shown that this factor, assisted by the NusE factor, 
can couple transcription to translation. While the NTD domain of NusG interacts with 
RNAP, its CTD interacts with the NusE factor, which is identical to the S10 protein of the 
30S ribosomal subunit. According to this similarity, NusG–CTD can interact with the S10 
protein and link transcription to translation (Burmann et al., 2010). 
 
1.4.3. Transcription termination 
Transcription termination is the final step of the transcription process that occurs at the  
end of the transcribed gene. In this step, the EC disappears due to three main 
modifications to the transcription bubble. These three changes can be illustrated as 
follows: the newly constructed mRNA dissociates from the template DNA, the 
transcription bubble collapses and RNAP itself detaches from the DNA. Bacterial 
transcription termination is carried out through one of two mechanisms: intrinsic 
termination and Rho-dependent termination (Figure 5). 
The preferable mechanism of transcription termination, intrinsic termination, occurs 
when the emerging RNA forms a loop stimulated by signals encoded within the nascent 
RNA itself. These signals are usually represented as a guanine- and cytosine-rich region 
followed by a chain of sequential uracil residues. When RNAP encounters the U-rich 
region, it pauses transcription, giving the nascent RNA the chance to fold and forming 
the loop generated from the binding of the Gs and Cs in the G- and C-rich region
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Figure 5. Bacterial transcription termination mechanisms. 
This figure was adapted from (Santangelo and Artsimovitch, 2011) to illustrate the two 
mechanisms of bacterial transcription termination. 
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(Artsimovitch and Henkin, 2009; Ray et al., 2016). The formation of the DNA/RNA 
hybrid in the U-rich region has a much lower stability than the hybrid with other normal 
sequences, as the bonds between the U and A residues are considerably weaker. Taking 
both the formation of the loop and the weak association between the DNA and RNA in 
the U-rich region into account, dissociation of the nascent RNA from the elongation 
complex is unavoidable (Martin and Tinoco Jr, 1980; Carafa et al., 1990). 
The second mechanism of transcription termination is known as Rho-dependent 
termination. The Rho protein belongs to the helicase family whose function is to unwind 
annealed nucleic acid strands, such as double-stranded DNA or DNA/RNA hybrids. This 
helicase enzyme, Rho, controls approximately 20% to nearly 50% of transcription 
termination processes in E. coli and acts by unwinding the DNA/RNA hybrid at the 5’ 
end of the nascent RNA strand (Brennan et al., 1987; Koslover et al., 2012; Hollands et 
al., 2014). Rho has six subunits that need to be organized in a hexameric structure to be 
capable of separating nascent RNA from template DNA (Geiselmann et al., 1992). The 
complete functional structure of the Rho termination factor must include two important 
domains: the amino-terminal domain, also known as RNA-binding domain (RNA-BD), as 
it binds to the nascent RNA, and a domain embracing the ATP-binding site, known as the 
ATP-binding domain (ATP-BD) (Dolan et al., 1990; Koslover et al., 2012). The Rho factor 
is recruited by a segment of the nascent RNA that is rich in cytidine residues, which is 
also known as the Rho utilization (rut) site. Rho moves along the nascent RNA following 
RNAP (5’3’). This movement requires energy that is provided by ATP hydrolysis of the 
ATP-BD of the Rho factor, which is activated by the interaction between nascent RNA 
and the Rho factor. Once RNAP reaches the terminator, the Rho factor catches up with it 
and starts unwinding the RNA/DNA hybrid. After that, RNAP, the nascent RNA and the 
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Rho factor are all released from the template DNA (Richardson, 2002). However, 
competitor proteins, such as the transcription elongation factor NusA, can work as an 
antiterminator by inhibiting Rho-dependent termination. This factor binds to a binding 
site on the nascent mRNA called the N utilization (nut) site. The inhibition takes place 
when the NusA and Rho factors compete to bind at the overlapping rut and nut sites 
(Qayyum et al., 2016). Interestingly, NusA was reported to help to achieve transcription-
intrinsic termination by interacting with the hairpin structure formed in this 
termination mechanism (Gusarov and Nudler, 1999). In addition, this factor was found 
to work in favor of transcription elongation by enhancing the overall EC stability 
(Gusarov and Nudler, 2001).  
Termination via these two mechanisms depends on RNAP pausing and disruption of the 
EC Figure 6. Controlling the sensitivity of RNAP to the DNA sequence and its structural 
elements that direct RNAP pausing can control termination at this level. Controlling 
pausing or escape from the pausing state using protein factor-RNAP interaction can 
modulate the sensitivity (Henkin, 2000). 
1.5. Gene regulation in bacteria 
Bacterial DNA encodes for the production of many cellular proteins through 
transcription and translation processes; however, these proteins do not need to be 
produced all the time. As some of these proteins need to be produced in higher or lower 
quantities than usual in specific bacterial life stages or to adapt to certain environmental 
conditions, bacteria need to be able to control the expression of genes responsible for 
the production of these proteins. During gene expression, several targets are available 
for regulating bacterial protein production. As a step of the gene expression process,
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Figure 6. Transcription elongation complex (TEC) pausing and termination. 
This diagram illustrates how paused TECs can lead to transcription termination. 
Adapted from (Nudler and Gottesman, 2002). 
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DNA transcription represents a target to be controlled in order to regulate gene 
expression. Three main transcriptional steps can be targeted to regulate bacterial DNA 
transcription: initiation, elongation and termination. 
 
1.5.1. Initiation regulation 
Bacterial transcription initiation is a multistep process starting with promoter 
recognition by DNA-dependent RNAP. This step is followed by a sequence of 
conformational changes in the RNAP complex and the DNA promoter itself in order for 
RNA synthesis to be initiated (Saecker, 2011). RNAP transcribes the DNA region located 
between +1 and the termination sites, producing a nascent RNA strand. At the 
recognition phase, the DNA is still in its original double-stranded form. After that, the 
DNA is unwound at the +1 site, creating a bubble that is known as the open complex. 
 
1.5.1.1. Sigma factors 
Transcription initiation can be controlled by RNAP affinity to promoters, attained by 
recruiting a  factor, and promoter strength. As already mentioned, factors recognize 
different promoters and have a high affinity to specific promoter elements. The first 
regulatory line for transcription initiation is to control the amounts and affinity of these 
factors to the promoters to which they bind.  factors with low affinity to promoters 
are assisted by different transcription factors and regulatory proteins. 
All bacteria contain one housekeeping  and several other alternative  factors. E. coli 
has six alternative factors that are highly regulated. For example, 38 is regulated by its 
synthesis, sRNAs and proteolysis. Other alternative σ factors are regulated by anti-sigma 
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factors. For example, σ28 (FliA) is regulated by an anti-sigma factor called flgM (Tlapak et 
al., 2017); and σ24 (σE) is controlled by an anti-sigma factor called RseA (El-Mowafi et 
al., 2015). 
 
1.5.1.2. Transcription factors (TFs) 
While  factors play an important role in the regulation of transcription initiation, the 
principal regulators for most responses are transcription factors. Thousands of genes 
are encoded in any bacterial genome, and these produce all of the proteins necessary for 
bacterial survival. These proteins are needed in different quantities, depending on the 
surrounding environment and bacterial conditions. Based on this differential need for 
various proteins, not all genes are expressed all of the time; such an unregulated 
approach to gene expression would jeopardize bacterial survival by wasting required 
energy and by producing more proteins than needed, which could be toxic for the cell. 
To overcome this issue, bacterial cells adopt several activation mechanisms by 
recruiting hundreds of activator proteins that assist in activating genes producing 
proteins limited to bacterial requirements. These activator factors vary in their 
functions and mechanisms of action. 
Transcription factors can positively or negatively affect transcription initiation by 
repressing or stimulating it. The regulatory activity of some of these proteins has been 
found to target only one or two promoters, while others have been found to control 
several promoters (Browning and Busby, 2004). Martinez-Antonio and Collado-Vides 
(2003) also claimed that seven transcription factors are considered to be global or 
master transcription factors: IHF, Fis, CRP, ArcA, NarL, Lrp and FNR. These global factors 
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control more than half of all genes. Conversely, approximately 60 transcription factors 
are specific to only one promoter (Browning and Busby, 2004). 
 
 1.5.1.2.1. Factors that activate transcription initiation 
This group of transcription factors includes factors that intervene with the interaction 
between RNAP and the DNA to stimulate transcription initiation (i.e., positive 
regulation). A very well reviewed example of this kind of factor is the cyclic-AMP (cAMP) 
receptor protein (CRP), also known as catabolite activator protein (CAP). At high levels 
of cAMP in the cell, CRP binds to cAMP and becomes activated as a cAMP-CRP complex. 
This activated complex stimulates transcription at different promoters, including the lac 
promoter, which controls expression of the genes that are responsible for the utilization 
of lactose (Ebright, 1993; Saha et al., 2015). This activator has an affinity to the CTD of 
the RNAP -subunit. It initially binds to the DNA at a target upstream of the target 
promoter DNA. Then, by its affinity to the CTD of the RNAP -subunit, the activator 
recruits RNAP. When the interaction occurs, other RNAP holoenzyme subunits interact 
with the downstream promoter sequence. 
Transcription activator proteins can be divided into two main groups: activators that 
directly interact with RNAP and activators that do not directly interact with RNAP. 
There are two classes of activation among the first group of activators, known as class I 
and II. In class I, activators bind somewhere upstream of the target promoter, so they 
can bind to the CTD of the RNAP -subunit and offer an opportunity for other RNAP 
subunits to contact the downstream promoter elements. CRP, which enhances the 
expression of the lactose operon by binding upstream of the lac promoter, provides an 
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extensively studied example of class I activation. (Ebright, 1993; Busby and Savery, 
2007). 
In class II, activators bind to a target overlapping the -35 promoter element and helps in 
converting RNAP-promoter closed complex (RPc) into RNAP-promoter open complex 
(RPo) (Feng et al., 2016). Therefore, the CTD of the RNAP -subunit binds upstream of 
the activator. In this scenario, the activator itself can interact with some parts of the 
RNAP holoenzyme, primarily region 4 of the σ subunit. Two very well understood 
examples for class II activation are the CRP protein at the promoter of the galactose 
operon and the bacteriophage λ cI protein at the λ PRM promoter (Niu et al., 1996; Busby 
and Savery, 2007; Lee et al., 2012). 
Members of the other group of activators help in regulating the transcription process 
without directly binding to RNAP. They bind to the DNA in order to change its 
conformation and make it easier for RNAP to bind and initiate transcription, or they 
change the DNA topology to make it easier for RNAP to reach the target promoter.  
At some promoters, transcription is suppressed as a result of the highly compact 
structure of bacterial DNA. This highly compact structure is created by the interference 
of some nucleoid-associated proteins (NAPs) like the histone for nucleoid structuring 
protein (HNS) and the integration host factor (IHF). For these promoters to be 
transcribed, activation factors need to disrupt the compact structure of the DNA. In 
some cases, the thermally assisted “breathing” of the DNA helps locate the target of 
initial DNA unwinding. The IHF protein functions by sharply bending the DNA, which 
can be either helpful or suppressive for transcription processes depending on where it 
binds. In some cases, bending the upstream DNA sequence can prevent it from hindering 
bound RNAPs, which eventually facilitates the transcription initiation process. Also, 
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when transcription factors bind well upstream of the promoter region, bending the DNA 
with IHF can bring those transcription factors and promoters together, which also 
favors transcription. In other cases, IHF binds to the promoter itself, preventing RNAP 
from binding, which suppresses the transcriptional activity of this promoter (Pagel et al., 
1992; Ueguchi and Mizuno, 1993; Busby and Savery, 2007; Browning et al., 2010). 
Fnr, which is activated by oxygen starvation, NarL and NarP are other transcription 
factors that regulate E. coli nir operon transcription without directly contacting RNAP. 
The Fnr factor binds upstream of the nir transcription start site between bases -41 
and -42. The NarL and NarP factors bind between bases -69 and -70 upstream of the nir 
transcription start site (Wu et al., 1998). 
 
 1.5.1.2.2. Factors that repress transcription initiation 
This group of factors includes proteins that negatively affect transcription initiation. 
Some of these factors inhibit transcription initiation by binding to a specific target in the 
DNA overlapping the promoter region. This binding hinders RNAP from binding to the 
promoter, which eventually deters transcription initiation. An example of this kind of 
regulation is the effect of the Lac repressor at the lac promoter. The lac operon (Figure 
7), when transcribed, assists the cell in the utilization of lactose, in the absence of 
glucose, as a source of energy. A protein known as Lac repressor or LacI mediates this 
switch. This protein binds to three different sites on the lac operon to repress the 
transcription of the three lac genes (lacZ, lacY and lacA). The lacZ gene is responsible for 
the production of the -galactosidase enzyme, which catalyzes the hydrolysis of 
-galactosides into monosaccharides. The second gene of the lac operon is lacY, which
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Figure 7. The lac operon. 
This figure shows the main components of the lac operon. 
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codes for a membrane protein that assists in transporting lactose into the cell known as 
the lactose permease (LacY) enzyme. The third gene is lacA, which is responsible for the 
production of an enzyme involved in sugar metabolism known as acetyltransferase 
(Ozbudak et al., 2004). This enzyme is also known as thiogalactoside transacetylase and 
assists in bacterial cell detoxification by preventing accumulation of metabolic 
compounds (Andrews and Lin, 1976). 
In the absence of lactose, LacI binds to its binding site on the DNA to inhibit the 
transcription of the lac operon. When lactose is present, a lactose isomer called 
allolactose binds to LacI and releases it from the DNA. This induces transcription of the 
lac operon to utilize cellular lactose, provided that CRP is active due to glucose being 
absent. LacI release can also be triggered by isopropyl--D-1-thiogalactoside (IPTG). 
IPTG works in favor of transcription initiation of the lac operon by binding to the 
repressor, which negatively affects its affinity to the DNA operator region (Reznikoff et 
al., 1985; Kercher et al., 1997; Bell and Lewis, 2001; Gatti-Lafranconi et al., 2013). 
Transcription initiation regulation can be attained by two other mechanisms: altering 
DNA topology and improving or demoting the promoter sequence (Reznikoff et al., 
1985). 
 
1.5.1.3. Transcription initiation regulation by altering DNA topology 
Regulation of transcription initiation can also be achieved by controlling DNA topology 
at the promoters. Bacterial DNA is highly supercoiled so it can be compacted and fit into 
a very small cellular space. As a result of this supercoiling, the DNA becomes highly 
tensed, which can negatively affect the rate of initiating transcription at particular 
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promoters. Proteins called topoisomerases can control the topology of bacterial DNA to 
regulate transcription initiation. There are two types of topoisomerases (I and II), and 
each one relaxes the double-helix DNA structure in a different way. Topoisomerase I 
cuts one DNA strand and passes the other strand around the temporarily introduced cut 
to relax the DNA. Topoisomerase II or bacterial gyrase relaxes the double-stranded DNA 
by cutting both strands and passing another double-stranded DNA through that cut 
(Wang, 1985; Wang, 1996). An example of a supercoiling-dependent promoter is the 
DNA gyrase promoter. DNA gyrase is an enzyme responsible for the DNA supercoiling in 
bacteria. However, DNA supercoiling modulates the synthesis of the gyrase enzyme 
itself. Up to 10-fold increase in gyrase protein synthesis was noticed after relaxing the 
DNA by blocking gyrase activity (Menzel and Gellert, 1983). 
 
1.5.1.4. Transcription initiation regulation by promoter modification 
Some bacteria have evolved different mechanisms in which they modify promoter bases 
or promoter structure in order to regulate transcription initiation. One of these 
mechanisms involves introducing a modification to the promoter bases. An example for 
this kind of modification is the methylation of these bases. This mechanism represents 
an evolutionary adaptation by which bacteria protect themselves from foreign viral DNA 
or transposons; the bacterial cell produces restriction enzymes that cut unmodified 
foreign DNA but not its own methylated DNA (Low et al., 2001). Methylation can also be 
used to prevent the binding of repressors at the pap and agn43 promoters in E. coli. In 
these two scenarios, the repressor binding is blocked by the action of the Dam 
methylase enzyme, leading to activation of the related promoters (Browning and Busby, 
2016). 
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Another mechanism for controlling gene expression includes promoter inversion. Some 
bacteria have been found to respond to a signal by turning the expression of specific 
genes on or off. This activation or deactivation of gene expression is achieved by flipping 
the whole promoter so it sends recruited RNAPs toward or away from its corresponding 
gene, respectively. This mechanism can be clearly seen in the fim operon, where the 
expression of type 1 fimbrial genes is regulated by inverting their promoter’s 
orientation. FimE and FimB recombinases regulate the direction of this inversion 
(Cerdeño-Tárraga et al., 2005; Browning and Busby, 2016). 
To adapt to changing environments, bacteria have evolved another strategy to regulate 
gene expression levels. This method involves mutations to an area of the promoter or 
the reading frame known as simple sequence repeats (SSRs), which carry a tract of one 
or more base repeats. These SSR regions are of different lengths between individual 
bacteria of the same population as well as from one generation to another. The 
difference in lengths leads to different promoter activities (Moxon et al., 2006; Browning 
and Busby, 2016). 
Some other promoters have non-optimal spacing between the -35 and -10 elements. 
Members of a family of activator proteins, known as the MerR family, activate 
transcription at promoters where the distance between the -35 and -10 elements is 
greater than the optimal spacing, which is normally 17 ±1 bp. As a result of this 
abnormal spacing, RNAP binds only to the UP and -35 elements but not the -10 element, 
rendering the formation of an open complex impossible. This problem can be resolved 
by the interference of MerR factors, which can correct the distance between the -35 and 
-10 elements by moving the -10 element to the correct position where it can bind to the 
RNAP  subunit (Brown et al., 2003; Busby and Savery, 2007; Lee et al., 2012). 
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Some of the MerR family members, can act as both repressor and activator. An example 
of this is CueR, that activates copA promoter. CueR binds to and causes some 
conformational changes to promoter DNA. These changes might positively or negatively 
affect promoter recognition by RNAP. When CueR binds the DNA in the absence of metal 
ion, it bends the DNA to a degree that negatively affects RNAP-promoter recognition by 
moving the -10 element away from domain 2 of  factor. However, when this binding 
takes place in the presence of metal ion, CueR acts as an activator by unwinding and 
kinking the DNA more, which favor RNAP-promoter recognition by bringing the -10 
element closer to the  domain 2 of RNAP. In both cases, some bases of the 
protein-binding site, located between the proteins’ two binding domains, are twisted 
more than others to cause this kink (Heldwein and Brennan, 2001; Philips et al., 2015). 
 
1.5.2. Elongation regulation 
Transcription elongation takes place after the recognition and binding of RNAP to a 
promoter. In this step, RNAP binds RNA nucleotides to each other in specific order that 
is complementary to the template DNA base order. Elongation cannot begin unless 
RNAP is completely clear of the promoter region. This escape is characterized by three 
different changes occurring to RNAP: dissociation of the recognition subunit ( factor) 
from RNAP, stabilization and robust binding of RNAP to the DNA template and primary 
movement of RNAP along the DNA template (Uptain et al., 1997).  
Transcription elongation can be regulated by three different factors: signals, accessory 
factors and polymerase modifications. Signals that regulate transcription elongation
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involve growth conditions and stress responses. For example, the elongation of the rrn 
operon in E. coli is directly affected by its stringent response through the ppGpp 
signaling molecule. This molecule is responsible for the stringent response in E. coli that 
can lower the elongation rate of RNAP in E. coli and increase the frequency of rrnB 
operon premature termination (Kingston and Chamberlin, 1981). Similar to growth 
conditions, stress responses can affect transcription elongation as well. Vidovic and 
colleagues (2011) proteomically analyzed the wild-type E. coli 0157, which is adapted to 
cold, and the rpoS mutant strain and recognized a difference in the expression of 21 
proteins between those two strains. They also found that the RpoS  factor regulates the 
expression of several proteins when E. coli is exposed to a cold shock. Some of these 
proteins are important for adaptation to cold stress and others are vital for the normal 
central metabolic pathways of E. coli. 
Accessory factors that regulate transcription elongation can be identified as proteins or 
small molecules that inhibit or promote transcription elongation and affect transcription 
elongation in different ways. Accessory factors can regulate transcription by affecting 
RNAP and/or its accessory proteins or the DNA itself. Some of these proteins, such as 
GreA and GreB, increase elongation rates by decreasing pausing or helping arrested 
transcription complexes resume elongation. Some other proteins affect the elongation 
process by binding to the nascent RNA transcript (such as the Rho protein described 
previously) or binding to the DNA template. Other protein factors affect the EC by 
altering its processivity through direct protein:protein interaction, leading to different 
changes in the activity of the EC. For instance, in phage , the N protein encoded by the 
phage initially binds to the nut site on the RNA strand. After that, a group of the host 
proteins (Nus factors and ribosomal S10 proteins) join the N protein on the nut site. This 
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protein complex then interacts with the elongating RNAP and alters its protein 
components, leading to a more stable complex that is resistant to downstream pauses 
and termination signals (Friedman and Court, 1995; Uptain et al., 1997; Henkin, 2000). 
Bacterial RNAP consists of several subunits participating to achieve transcription. It has 
been found that these subunits have many sequence conservations among bacterial 
species (Allison et al., 1985; Archambault and Friesen, 1993). This leads to the 
suggestion that these proteins represent a possible target for transcription elongation 
regulation. Some of the RNAP subunits experience changes such as phosphorylation and 
glycosylation that can affect RNAP efficiency. However, in eukaryotes, these types of 
changes do not affect transcription unless they occur to large RNAP subunits. In 
eukaryotes, the C-terminal of the largest subunit of RNAP II contains a repeated 
sequence of heptapeptide amino acids, which are highly phosphorylated. RNAP II with a 
highly phosphorylated C-terminus has been found to be more efficient in elongation 
than RNAP II with a non-phosphorylated C-terminus (Uptain et al., 1997). In E. coli, 
phosphorylation of the and’ subunits was found to be associated with the shutoff of 
RNA synthesis. This connection emphasizes the association between phosphorylation 
and elongation regulation (Cozzone, 1988). 
The transcription EC has the ability to introduce conformational changes to the 
transcribed DNA segment. As bacterial DNA is double-stranded and highly supercoiled, 
RNAP and its nascent RNA need to rotate around the DNA during elongation, which is 
not possible at all times as the DNA is stored in a highly compact structure and the RNAP 
itself is very large in comparison to the chromatin filaments. As a result, RNAP, with 
topoisomerase I ahead of it, forces the DNA to rotate around its axis, resulting in an 
increasing torsional stress in the downstream DNA. The introduced torsional stress may 
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slow the movement of the proceeding elongation complex and can play an important 
role in transcription regulation (Liu and Wang, 1987; Kouzine and Levens, 2007; 
Kouzine et al., 2013). These facts led to the twin domain hypothesis by Liu and Wang in 
1987. This hypothesis illustrates that ECs change the topology of DNA by leaving 
negative supercoiling behind them and increasing positive supercoiling ahead of them 
when their rotation is obstructed during active transcription (Liu and Wang, 1987). 
Moreover, the bacterial chromosome is structured in a way that is compatible with the 
bacterial cell cycle, which might play a role in elongation regulation. Bacterial 
chromosome consists of two main structures, which are the topologically constrained 
loops, or topological domains, and the higher structures known as macrodomains. The 
topologically constrained loops are formed by connections resulted from the negative 
supercoiling of the DNA. These loops are stabilized by the attachment of some DNA 
binding proteins along bacterial DNA to protect the cell against DNA over relaxation 
during replication and other processes by which the DNA is unwound (Postow et al., 
2004). During the repair of DNA double-strand breaks, DNA topological domains help by 
keeping DNA ends close to each other (Wang et al., 2013). Macrodomains are suggested 
to be formed by some sequence specific binding proteins. The formation of these 
macrodomains is central for bacterial DNA compaction.  There are four macrodomains 
in E. coli chromosome (Dame et al., 2011; Wang et al., 2013). 
 
1.5.3. Termination regulation 
Transcription termination occurs at the end of each transcriptional process or when 
cells need to abort the transcription process. This process is characterized by two 
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events: the release of the newly synthesized nascent RNA from the transcription 
complex and the detachment of the transcribing RNAP from the template DNA. The 
termination step can be regulated by different mechanisms. One of these mechanisms is 
directly related to the Rho-dependent termination mentioned previously. When the Rho 
protein binds to the transcript and moves towards the transcript’s 3’ end, it catches up 
with stalled RNAP complexes at pausing sequences. Once the Rho protein contacts 
RNAP, RNAP terminates transcription and releases both the RNA transcript and 
template DNA. The regulation of this process can be attained by controlling the 
sensitivity of RNAP to the pausing sequences and by controlling the Rho protein supply 
to the RNA transcript or RNAP (Henkin and Yanofsky, 2002). 
Another mechanism of regulating transcription termination is by employing the 
transcription termination–antitermination process. This process is commonly known as 
transcription attenuation. In this process, bacterial cells respond to a metabolic signal 
and instruct RNAP to terminate transcription or to continue transcribing the subsequent 
genes of the same operon (Merino and Yanofsky, 2005). Attenuation occurs when the 
RNA transcript forms one of two structures (i.e., hairpin loops): the antiterminator loop 
or the terminator loop. The formation of the antiterminator loop prevents the formation 
of the terminator loop and allows the transcription process to proceed. Alternatively, 
the terminator hairpin loop leads to RNAP being stalled and transcription being 
terminated (Lathe et al., 2002). 
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1.5.4. Gene regulation by location 
Regulation of gene expression can also be attained by means other than the 
aforementioned mechanisms and factors. Specifically, it has been discovered that gene 
positioning within the chromosome can affect gene expression in both prokaryotes and 
eukaryotes (Dobzhansky, 1936; Bryant et al., 2014). Some genes were found to be less 
active or even silent when their locations changed on the chromosome. Other genes 
demonstrated increased expression when their location changed. These observations 
demonstrate that gene expression can be regulated by the location of the gene on the 
chromosome (Bryant et al., 2014). 
During their studies on Pseudomonas putida using lacZ fusions to different promoters, 
de Lorenzo and colleagues (1993) found that the activities of several catabolic systems 
differ significantly depending on the promoter’s location on the chromosome. In another 
study, Sousa and colleagues (1997) suggested that chromosomal positioning can 
modulate gene expression and change gene activity in response to changing 
environments. 
Gene expression is likely altered according to the gene’s position on the chromosome 
according to two means. First, expression decreases as the distance between the gene 
and the origin of replication (oriC) increases. In other words, genes located near the oriC 
have more copies, particularly at high rates of growth when multiple rounds of 
chromosome replication are initiated. Second, DNA compaction and supercoiling have 
been found to affect gene expression. Therefore, gene expression can be altered 
significantly by changing the location of the gene along the chromosome (Block et al., 
2012). 
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Schmid and Roth (1987) conducted a study on the effect of location on the expression of 
the his gene of Salmonella typhimurium. The researchers constructed large numbers of 
strains carrying translocations of the his gene at defined chromosomal positions to test 
if these translocations had any effect on gene expression. Schmid and Roth eventually 
observed that gene expression was different in each location and suggested that these 
differences resulted from the differences in gene dosage of chromosomal sites; this 
finding again supports the notion that genes located near oriC have more copies than 
distant genes. 
 
1.6. Quantitative aspects of gene expression 
1.6.1. Effect of rifampicin on transcription 
Rifampicin, also known as rifamycin, is one of the most important antibiotics in clinical 
use. This antibiotic, which works as an inhibitor of RNAP, was discovered decades ago 
and has been used as a treatment for serious bacterial infections. It has been found that 
mutations introduced to the RNAP  subunit lead to the development of rifampicin 
resistance in E. coli, suggesting that this antibiotic interferes with the transcription 
initiation step (Rabussay and Zillig, 1969). Furthermore, a study published by Hinkle 
and his coworkers in 1972 proved that rifampicin has no effect on RNAP binding to 
bacterial DNA (Hinkle et al., 1972). Another study showed that rifampicin binds to a 
pocket in the RNAP  subunit fairly close to the RNAP active site; once RNAP escapes the 
promoter region and produces a long RNA chain, it becomes completely resistant to 
rifampicin. The same study illustrated that, after rifampicin treatment, RNAP produces a 
very short RNA chain (2–3 nucleotides long) and then stops elongating (Campbell et al., 
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2001). The sum of findings from these three studies support the fact that rifampicin acts 
by physically blocking the nascent RNA channel in RNAP. However, more recent studies 
have reopened the issue of what rifampicin does to inhibit transcription. One of these 
studies has suggested that steric blocking, of the RNA exit channel by rifampicin, alone is 
not enough to inhibit transcription. This study has proposed another component of the 
inhibition mechanism. This component is represented by an allosteric signal resulted 
from the binding of rifampicin to the RNAP molecule. This signal negatively affects the 
phosphodiester bond formation by preventing the binding of Mg2+ ion, which eventually 
leads to the release of short RNA transcripts (Artsimovitch et al., 2005). Generally, 
rifampicin-treated RNAPs will be trapped at the promoter only. This property has 
allowed researchers to study RNAP distribution along the bacterial chromosome and 
RNAP binding sites around the whole genome (Grainger et al., 2005; Cho et al., 2009). 
After rifampicin treatment, each promoter will be occupied by one RNAP. Assuming 
100% promoter occupancy after rifampicin treatment will assist in further calculations 
regarding promoter activity. 
 
1.6.2. Promoter strength 
Promoter strength can be defined by the frequency at which RNA polymerase initiates 
transcription. This strength depends primarily on promoter sequence, which plays a 
vital role in the distribution of RNAP among the massive numbers of promoters. It has 
been revealed that each promoter has two conserved regions that are recognized by the 
σ factor of RNAP. These conserved regions are known as consensus sequences (Wosten, 
1998). The two consensus regions are the -10 and -35 promoter elements or hexamers. 
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The activity of each promoter depends mainly on the sequences of these two hexamers. 
Having the -10 and -35 hexamers with sequences identical or near to the consensus 
sequences increases the promoter strength and vice versa. Another two promoter 
elements were found to play significant role in transcription initiation: the extended -10 
element and the UP element. The extended -10 element consists of 3 to 4 bp and is 
situated directly upstream of the -10 hexamer (Browning and Busby, 2004). In other 
studies, the extended -10 element was found 1 bp upstream of the -10 hexamer (Burr et 
al., 2000; Mitchell et al., 2003). Both of these observations are accurate, as the 
extended -10 element can be found adjacent to the -10 hexamer or separated from it by 
1 bp. A functional extended -10 element is not present in some primitive promoters. 
This element is recognized by domain 3 of  factor. Some  factors have domain 2 only 
to bind to -10 elements and some other have domains 2 and 4 to bind to -10 and -35 
elements, respectively. Domain 3 has evolved to recognize the sequences located 
between these two elements, which involve the extended -10 element. So, the 
extended -10 element has, presumably, evolved after the -10 and -35 elements. 
 
The UP element consists of approximately 20 bp situated upstream of the -35 hexamer. 
The length of the spacer sequence between the -10 and -35 hexamers is also important 
for the transcription process. A previous study proved that the optimal length for this 
region is 17 bp. This study compared promoters with 16-, 17- and 18-bp spacer regions 
and found that the rate of open complex formation when the spacer region is 17-bp long 
is higher than when it is 16- or 18-bp long (Stefano and Gralla, 1982). 
Like all other promoter elements, the UP element plays a role in activating transcription. 
Most E. coli promoters have an UP element upstream of the -35 element. This element is 
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rich in A and T bases which is recognized by the CTD of the RNAP subunit. It has been 
found that the presence of the UP element upstream of some E. coli promoters increases 
the promoters’ activity. This activity immensely decreased after introducing a mutation 
to the RNAP subunit, which supports the notion that the UP element has an important 
role in RNAP recruitment (by contacting the CTD domain of RNAP  subunit) and 
promoter activity and this has been quantified by Ross and her co-workers (Ross et al., 
1993). 
 
1.6.3. Promoter strength measurements 
There are several techniques that can be used to measure promoter strength, such as 
reporter gene assays and electrophoretic mobility shift assays (EMSA). Promoter 
strength can be estimated by measuring any reporter gene product activity, such as the 
lacZ gene product (-galactosidase) enzyme activity, assuming that this activity reflects 
promoter strength. The principle of the -galactosidase assay is to measure the 
hydrolysis of O-nitrophenyl-β-D-galactopyranoside (ONPG). ONPG is hydrolyzed by 
water giving galactose (colourless) and O-nitrophenol (yellow). The amount of 
O-nitrophenol formed is normally proportional to the amount of -galactosidase and the 
reaction time. The amount of O-nitrophenol produced can be measured by determining 
the absorbance at 420 nm. At the end of the assay, the reaction is stopped by adding 
Na2CO3, leading to the rapid increase in the reaction mixture pH to around 11. At this 
pH, a certain amount of the O-nitrophenol is converted to the yellow-coloured anionic 
form and -galactosidase is inactivated. 
  
 
 
45 
EMSA is a technique mainly used to study protein-RNA or protein-DNA interactions. 
EMSA can assess binding complexes and determine if a protein is capable of binding to a 
given DNA or RNA sequence. This assay depends on the electrophoretic separation of 
protein-RNA or protein-DNA mixtures on an agarose or polyacrylamide gel depending 
on their sizes. Therefore, if the protein is capable of binding to DNA or RNA, the resulting 
complex will move slowly through the gel and demonstrate a band with a larger size 
than a band of protein alone. This technique can be applied to assess promoter strength 
by adding different concentrations of RNAP (protein) with the promoter. Strong 
promoters will produce binding complexes (promoter-RNAP complexes) with low RNAP 
concentrations. However, weak promoters will need higher RNAP concentrations to 
produce complexes. 
Several previous studies have tried to indirectly measure promoter strength and RNAP 
flux through given genes in living cells. Kelly and colleagues (2009) tried to indirectly 
measure promoter strength by fusing them to genes coding for green fluorescent 
protein (GFP) and calculate promoter strength depending on the amount of GFP 
produced by these genes under the control of different promoters. Using their 
calculations, which involved estimates of the rate of GFP synthesis, folding and 
maturation, and RNA half-life, they were able to measure polymerase per second (PoPS) 
for their promoters. Another recent study used computational methods to design 
genetic circuits, which then inserted in different specific locations on the DNA and 
transformed into bacterial strain. They were able to indirectly calculate the amount of 
RNAP per second per the standard promoter used in their study (Nielsen et al., 2016). 
To date, to my knowledge, no reliable technique has been developed to directly measure 
promoter activity in vivo. The two aforementioned techniques and many other 
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techniques rely solely on measuring genes’ final products. The reporter gene assay 
measures the amount of final product produced by a gene, which can be compared to 
another gene’s products to evaluate which gene is stronger. The EMSA technique 
depends on measuring the sizes of protein-DNA or protein-RNA complexes in vitro and 
changing the protein concentrations to determine which protein concentration 
produces binding complexes. Hence, both techniques are indirect and in vitro. 
Considering a lack of reliable methods for measuring promoter activity directly in 
real-time, as inside the cell, an alternative technique for measuring promoter activity is 
desirable. In this study, I developed a new, real-time method to directly assess promoter 
strength depending on RNAP activity. This method allowed us to yield more 
measurements regarding promoter strength, such as the promoter competitivity, 
promoter occupancy index (POI), promoter escape index (EI), fragment occupancy 
percentage (FOP) and PoPS. 
All samples were tested using a chromatin immunoprecipitation (ChIP) experiment to 
immunoprecipitate DNA fragments that were bound to RNAP in each sample. The 
resultant DNA fragments were quantified by quantitative polymerase chain reaction 
(qPCR) using specific primers. qPCR employs the same procedural steps as conventional 
PCR. However, in qPCR, as the DNA is labelled with a fluorescence dye, the amount of the 
amplified DNA can be accurately counted by monitoring the fluorescence emitted in 
each thermal cycle. At the end of each qPCR run, readings are given as cycle threshold 
(Ct), which describes how many cycles emitted a fluorescence exceeding the background 
signal. The Ct value is relative to the initial amount of the DNA, in that fluorescence will 
be detected earlier in samples with high initial DNA concentrations (i.e., samples with 
high DNA concentrations will yield low Ct values). After qPCR, these Ct values were used 
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to calculate the amount of DNA fragments of interest that were occupied by RNAP in 
each sample. These experiments were performed in triplicate for each sample as a 
biological repeat. For each biological repeat, qPCR was performed in triplicate as a 
technical repeat. 
This new direct method developed in this study was applied on two different systems: 
the lac operon on the chromosome and the lac operon in pRW50 with different 
promoters. For the lac operon on the chromosome system, the lac operon activity was 
tested on the chromosome twice: one time before and after rifampicin treatment and 
another time before and after IPTG treatment. In qPCR, seven newly designed primer 
pairs were used. A primer pair for the promoter region (lac0), five sets of primer pairs 
distributed along the lac operon (lac1, lac2, lac3, lac4, and lac5) and a primer pair for a 
control region. For the lac operon in pRW50, nine synthetic promoters with different 
activities inserted into the pRW50 plasmid, just before the lac operon, were tested with 
and without rifampicin treatment. Then, qPCR was applied using four sets of primer 
pairs to quantify how many RNAPs were attached to the promoter, two downstream 
regions on the lacZ gene and a control region.  
The Cts obtained from all qPCR tests were used to calculate the occupancy value of each 
region. These occupancy values were then used to calculate how competitive is the 
promoter in recruiting RNAPs, how efficiently the RNAP recruited by the promoter (i.e., 
POI), how efficiently the promoter allows RNAP to escape (i.e., EI), the time interval 
between RNAPs transcribing downstream regions (Tint), downstream fragments 
occupancy percentage (FOP) and the rate at which RNA polymerase moves past a given 
position on the DNA (i.e., PoPS). 
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Chapter 2 
Materials and methods 
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2.1. Suppliers 
All chemicals, media, reagents and consumables were purchased from the following 
suppliers, unless otherwise specified: GE Healthcare, SIGMA-ALDRICH, Agilent 
Technologies and Neoclone Biotechnology.  
 
2.2. Bacterial strains, media, antibiotics, growth conditions 
and bacterial storage 
2.2.1. Bacterial strains 
Two E. coli strains were used throughout this study: E. coli M182 (genotype: 
(lacIPOZY)X74, galK, galU, strA), obtained from J. Beckwith (1969); and E. coli MG1655. 
The M182 strain was transformed with pRW50 plasmids containing promoters used in 
this study to test the promoters’ activities and RNAP flux in the lacZ gene. The MG1655 
strain was used to test the activity of lac promoter on the chromosome and RNAP flux in 
the lacZ gene. 
 
2.2.2. Media 
Both solid and liquid media in this study were prepared by dissolving the required 
amounts of reagents in distilled water. 
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2x Luria-Bertani (LB) broth (1 L): 
20g tryptone 
10g NaCl 
10g yeast extract. 
Distilled H2O to 1 L 
 
LB Broth with agar (Lennox) (1 L):  
15g agar 
10g tryptone 
5g NaCl 
5g yeast extract. 
Distilled H2O to 1 L 
 
MacConkey agar (1 L): 
40 g MacConkey agar base 
10 g Lactose 
Distilled H2O to 1 L 
 
After preparation, all liquid media were divided into small aliquots to avoid 
contaminating large amounts of media. All liquid and solid media were sterilized by 
autoclaving at 121°C for 20 minutes. LB broth with agar was allowed to cool down to 
50°C to 55°C before the addition of tetracycline. Then, it was poured into petri dishes 
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under sterile conditions and allowed to set on the bench. All plates were stored at 4°C 
and allowed to dry at 37°C in an incubator before use. 
 
2.2.3. Antibiotics used in this study 
Tetracycline 
200 mg tetracycline  
Methanol to 20 ml 
 
Rifampicin (50 mM) 
1 g rifampicin 
Methanol to 24 ml 
Tetracycline and rifampicin were used in this study. Tetracycline was used at a final 
concentration of 35g/ml for the selection of plasmid-encoded resistances, as all of the 
plasmids used in this study held a tetracycline resistance gene. Rifampicin (Sigma) was 
used at a final concentration of 50 M to treat the cells for 15 minutes (when required) 
just before OD650 reached 0.4 (Grainger et al., 2005). 
 
2.2.4. Growth conditions 
Agar plates 
Bacterial cells were streaked onto appropriate agar plates (containing tetracycline 
where appropriate) for single colonies and incubated at 37°C in an incubator overnight. 
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Liquid media 
For a 5 ml overnight liquid culture, a single colony was picked from the appropriate 
overnight culture plate and inoculated in 5 ml of the required media (containing 
tetracycline where appropriate) in 25 ml conical flasks. Flasks were then incubated at 
37oC in a shaker overnight. 
For media used in the ChIP experiment, a calculated amount from the overnight liquid 
growth was inoculated in 40 ml of 2x LB media (tetracycline supplemented where 
appropriate). For testing RNAP flux through the lac operon, the 40 ml of media was 
supplemented with M IPTG to overcome the lac repressor effect (Reznikoff, 1992; 
Wilson et al., 2007). 
 
2.2.5. Bacterial storage (glycerol stock preparation) 
Bacterial cells were plated on agar plates by streaking (for single colonies) and 
incubated at 37°C overnight. A single colony was picked and inoculated in 5 ml of 2x LB 
in a 25 ml conical flask and incubated with shaking overnight in a 37oC incubator. Next, 
300 l of the overnight culture was mixed with 700 l of 50% glycerol (Fisher 
Chemicals) and kept frozen at -80°C until use. 
 
2.3. Plasmid DNA 
The pRW50 plasmid was used as a vector for different promoters used in this study.  
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This vector contains different regions, such as the lac operon located directly 
downstream of the promoter’s region and a control region with no expression at all 
(Figure 8). This plasmid DNA also contains a tetracycline resistance gene for the 
selection of desired cells only.  
 
2.4. Buffers and Solutions 
2.4.1. Solutions for general use 
70% ethanol (100 ml) 
70 ml of 100% ethanol 
Distilled H2O to 100 ml 
 
50% glycerol (50 ml) 
50 ml of 100% glycerol 
50 l distilled H2O 
 
2.4.2. ChIP buffers 
Tris-buffered saline (TBS) (500 ml) 
50 mM Tris, pH7.6 
150 mM NaCl 
Distilled H2O to 500 ml 
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Figure 8.  The map of pRW50 plasmid used in this study 
This figure shows a diagram of the pRW50 plasmid and the approximate locations of 
lac1357, lac2720, the control region, promoter’s cloning site, the origin of replication 
(ori) and the tetracycline resistance gene (TetR) (Lodge et al, 1992). 
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FA Lysis buffer (100 ml) 
10 mM Tris, pH8.0 
20% sucrose 
50 mM NaCl 
10 mM EDTA 
Distilled H2O to 100 ml 
20 mg/ml lysozyme (to be added immediately before use) 
 
IP (Immunoprecipitation) buffer (300 ml) 
50 mM HEPES-KOH, pH7.5 
150 mM NaCl 
1m M EDTA 
1% Triton X-100 
0.1% Na deoxycholate 
0.1% SDS 
Distilled H2O to 300 ml 
 
IP buffer + alt (100 ml) 
50 mM HEPES-KOS, pH7.5 
500 mM NaCl 
1 mM EDTA 
1% Triton X-100 
0.1% Na deoxycholate 
0.1% SDS 
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Distilled H2O to 100 ml 
 
IP wash buffer (100 ml) 
10 mM Tris, pH8.0 
250 mM LiCl 
1 mM EDTA 
0.5% Nonidet P-40 
0.5% Na deoxycholate 
Distilled H2O to 100 ml 
 
TE (Tris/EDTA) buffer (100 ml) 
10 mM Tris, pH7.5 
1 mM EDTA 
Distilled H2O to 100 ml 
 
1x Elution buffer (100 ml) 
50 mM Tris, pH7.5 
10 mM EDTA 
1% SDS 
Distilled H2O to 100 ml 
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2.4.3. Reporter gene assay solutions 
Z buffer (1 L) 
0.75  g  of  KCl 
0.246  g  of  MgSO4•7H2O 
8.53  g  of  Na2HPO4 
4.866  g  of  NaH2PO4•2H2O 
2.7 ml  of  2-Mercaptoethanol 
Distilled H2O to 1 L 
 
1 M Na2CO3 (1 L) 
106 g Na2CO3 
Distilled H2O to 1 L 
 
ONPG (O-nitrophenyl-β-D-galactopyranoside) (100 ml) 
400 mg ONPG 
Z buffer to 100 ml 
The 100 ml ONPG was divided in small aliquots, stored at 4oC and used at room 
temperature. 
 
2.4.4. Competent cells preparation buffers 
TFB I buffer (125 ml) 
0.368 g KoAc 
1.24 g MnCl2•4H2O 
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1.51 g RbCl 
0.18 g CaCl2 
18.75 ml 100% glycerol 
pH5.8 adjusted with 1 M Acetic acid 
Distilled H2O to 125 ml 
Filter sterilized and incubated at room temperature 
 
TFB II buffer 
0.21 g Na MOPS 
1.10 g CaCl2•2H2O 
0.121 g RbCl 
15 ml 100% glycerol, pH 7 
Distilled H2O to 125 ml 
Filter sterilized and incubated at room temperature 
 
2.4.5. Gel electrophoresis 
5x TBE (Tris/Borate/EDTA) buffer (1 L) 
54 g Tris 
27.5 g boric acid 
20 ml of 0.5 M EDTA 
pH8.3 adjusted by HCL 
Distilled H2O to 1 L 
The working solution for agarose gels was 0.5x and for acrylamide gels was 1x. 
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2.4.6. Stock acrylamide solution (250 ml) 
62.5 ml of 30% acrylamide (PROTOGEL) – 7.5% final concentration 
12.5 ml of 5% glycerol – 5% final concentration 
50 ml of 5x TBE – 1x final concentration 
125 ml distilled H2O 
This was prepared in a 250 ml measuring cylinder and covered with Parafilm to be 
mixed by inversion. After mixing, the volume was transferred to a Duran bottle and 
covered by foil. The bottle then was labeled properly and stored at 4°C. 
 
10% Ammonium Persulphate (APS) (100 ml) 
1 g APS 
100 ml distilled H2O 
The 100 ml was divided into small aliquots (600 l each) and frozen at -20oC. 
 
For large acrylamide gels 
50 ml of 7.5% acrylamide 
500 l of 10% APS 
75 l TEMED 
The TEMED and APS should be added just before pouring the gel. 
 
For small acrylamide gels 
10 ml of 7.5% acrylamide 
100 l of 10% APS 
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15 l TEMED 
The TEMED and APS should be added just before pouring the gel. 
2.5.  Promoter manipulation 
2.5.1. Oligonucleotides design 
My starting promoter was KAB-TTTG (Burr et al., 2000), which carries a -35 element of 
TAGACA (consensus is TTGACA), an extended -10 element of TTTG (consensus is TGTG) 
and a -10 hexamer of TATGGT (consensus is TATAAT). This promoter is designed to be 
located directly downstream of the EcoRI site and 6 bp before the transcription start site 
of the lac operon. The sequence of this promoter was manipulated in different ways 
(one, two or three mutations each time) to get eight more related promoters with 
different activities. Five of these new promoters were designed by designing an 
oligonucleotide (Alta Biosciences, University of Birmingham) carrying the required 
sequence of each promoter. Four promoters, including the starting promoter, were 
obtained from two previous studies (Burr et al., 2000; Chan and Busby, 1989). The 
sequences (5’3’) of the oligonucleotides used to design the new five promoters are 
shown in Table 1. 
2.5.2. Conventional polymerase chain reaction 
Polymerase chain reaction (PCR) was performed on the pRW50 plasmid DNA containing 
our starting promoter (KAB-TTTG) as a template to change its sequence. A single 100 l 
reaction was prepared for each promoter to be designed. Each reaction contained one of 
the newly designed oligonucleotides along with another reverse oligonucleotide
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Promoter 
name 
Oligonucleotide sequence Oligo code 
KAB-TTTG 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ - 
BKS103 5’ TAGATCTGAATTCTAGACAGCTGCATGCATCTTTGTTATAATTATTTCATACC 3’ D83457DL 
BKS104 5’ TAGATCTGAATTCTTGACAGCTGCATGCATC 3’ D83149BS 
BKS106 5’ TAGATCTGAATTCTAGACAGCTGCATGCATCTTTTTTATGGTTATTTCATACC 3’ D83161DL 
BKS108 5’ TAGATCTGAATTCTTGACAGCTGCATGCATCTGTGTTATAATTATTTCATACC 3’ D83151BS 
BKS109 5’ TAGATCTGAATTCTACTGTGCTGCATGCATCTTTTTTATAATTATTTCATACC 3’ D83152BS 
 Oligonucleotides used to design the new promoters. 
This table shows the sequences (5’3’) of the oligonucleotides used to design the new promoters with the short names of the 
promoters to be designed. It also shows the sequence of the starting promoter (KAB-TTTG). The -35 elements are shown in blue, 
the extended -10 elements are shown in green (bases -16 and -17) and yellow (bases -14 and -15) and the -10 elements are shown 
in red. 
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(D10527) binding downstream of the promoter area in a PCR reaction. The contents and 
thermal conditions of each PCR reaction are shown in Table 2 and Table 3, respectively. 
PCR products were then purified using the QIAquick PCR Purification Kit (QIAgen) 
according to manufacturer’s instructions and using buffers supplied with the kit. This 
step was performed to dispose of the extra PCR reagents. The final product was eluted in 
84 l of distilled H2O. 
 
2.5.3. Digestion of the newly constructed DNA with restriction 
enzymes 
All PCR products, obtained using the newly designed oligonucleotides, were intended to 
contain recently constructed promoters to replace the starting promoter (KAB-TTTG). 
As these promoters are located between the EcoRI and HindIII restriction sites, high 
fidelity EcoRI (HF EcoRI) and HF HindIII restriction endonucleases were used to digest 
all PCR products in preparation to insert them into the pRW50 plasmid DNA. Table 4 
shows the volume of each component used in each digestion reaction. Digestion 
reactions were then incubated at 37°C for three hours, cleaned up using the QIAquick 
PCR Purification kit (QIAGEN) according to manufacturer’s instructions and eluted in 30 
l of elution buffer (EB). 
 
2.5.4. Large acrylamide gel for digestion products 
A large acrylamide gel was prepared to run the digestion products of the DNA. This was 
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Component Volume 
Template DNA (pRW50) 5 l 
10 M new designed forward primer 10 l 
10 M reverse primer (D10527) 10 l 
10x buffer 10 l 
5 mM dNTPs 2 l 
Accuzyme (last solution to add) 2 l 
H2O 61 l 
Total 100 l 
 Conventional PCR reaction components. 
This table illustrates the contents of each (100 l) conventional PCR reaction. 
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PCR step Temperature Time Repeat 
Initialization step 95oC 5 minutes 1 
Denaturation step 95oC 30 seconds  
35 Annealing step 55oC 30 seconds 
Extension step 68oC 30 seconds 
Final extension 
step 
68oC 10 minutes 1 
Final hold 4oC ∞ -- 
 Conventional PCR thermal conditions. 
This table illustrates the thermal conditions of each conventional PCR run. It shows the 
temperature , time and repeat of each step of the PCR run. 
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Component Volume 
DNA ( PCR product) 82 l 
Cut smart buffer 10 l 
HF EcoRI 4 l 
HF HindIII 4 l 
 Components of each digestion reaction. 
This table shows the components of each (100 l) digestion reaction using HF EcoRI and 
HF HindIII. 
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done to find the EcoRI-HindIII band, cut it and extract the DNA from the gel slice by 
electroelution. Acrylamide gel glass plates were first cleaned with ethanol. Then, the 
spacers were greased on both sides and at the junctions between the side and bottom 
spacers. The bottom and both sides of the glass plates were clamped, making sure there 
was no gap between the side and bottom spacers. After assembly, the plates were placed 
diagonally on one side with the top lifted up to allow the pouring of the gel. The 
acrylamide gel was prepared, mixed gently by swirling and poured into the plate 
assembly continuously, avoiding air bubbles. Finally, the comb was inserted and 
clamped to allow the formation of several wells for the samples to be loaded into. The 
gel was then allowed to set for ~30 minutes and the comb was removed. To load the 
samples, the bottom spacer was removed and the plates were installed vertically in an 
electrophoresis apparatus. Next, 6 l gel loading dye, blue (6x) (NEW ENGLAND 
BioLabs), and 3 l of 50% glycerol were added to each digested DNA sample and loaded 
on the gel with 25 l of HyperLadder 100 bp (BIOLINE). The gel was run at 40 mA for 3 
to 4 hours (depending on the size of the fragments). At the end of the run, the gel was 
stained in ethidium bromide for 15 minutes. The gel was then removed from the 
ethidium bromide stain and laid flat on a UV light box after cleaning with ethanol. After 
identifying the EcoRI-HindIII band, the band was cut out with a clean razor blade and 
placed into a clean, labelled tube. 
 
2.5.5. Electroelution 
Electroelution was performed to extract the EcoRI-HindIII DNA fragments from the 
acrylamide gel slices obtained previously. A piece of dialysis tubing with a clip attached 
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to one end was washed thoroughly with distilled H2O, and 200 l of EB buffer was added 
into it. The gel slice was then transferred with a small clean spatula to the dialysis tube. 
After that, another clip was attached to the other end of the tube to close it, taking care 
to eliminate air bubbles. The dialysis tube was then placed into an electroelution tank 
filled with 0.1x TBE buffer  (Tris base, boric acid and ethylenediaminetetraacetic acid 
[EDTA]) with the gel slice pushed to one side of the tube leaving, space for DNA to 
migrate into. The dialysis tube was then weighed down into the TBE buffer using a glass 
slide and electroelution was started at 30 mA for 30 minutes. The dialysis tube was then 
removed, one cap was taken off and the liquid was transferred from the dialysis tube 
into a clean, labelled eppendorf tube. The dialysis tube was washed with 200 l of EB 
and the washing was added to the sample. To obtain the DNA, 400 l of phenol:CHCl3 
was added to the sample and the sample was vortexed for 10 seconds. Sample was then 
centrifuged at 13000 rpm for 5 minutes. After centrifugation, three layers appeared in 
the tube: the upper aqueous phase containing DNA, the white interface and the 
phenol:CHCl3. The upper aqueous layer was removed into a fresh tube taking care to not 
pipette any phenol. Next, 1/10 of the sample volume of Na acetate (pH 5.2) and two 
volumes of the final mixture of ice-cold ethanol were added to the sample. To help 
precipitate the DNA, 1 l of glycogen was added and mixed well. The mixture was then 
stored at -20°C overnight or at -80°C for ~1 hour. Next, the mixture was centrifuged at 
4°C and 13000 rpm for 15 minutes. The supernatant was poured off, leaving a white 
pellet behind, and 1 ml of ice-cold 70% ethanol was added without mixing followed by 
centrifugation at 4oC and 13000 rpm for 10 minutes. The supernatant was poured off 
and the pellet was dried using a Spedivac for approximately 12 minutes. The pellet was 
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then resuspended in 25 l of sterile distilled H2O. The final product included the EcoRI-
HindIII DNA fragments containing the new designed promoters (insert DNA). 
2.5.6.  Small acrylamide gel 
In a subsequent step, 1 l of the final product was run on a mini acrylamide gel to 
determine the quantity of the prepared insert DNA. The previously described 
polyacrylamide gel procedure was performed again, but small acrylamide gel glass 
plates were used in this step. In addition, the gel was checked on the UV light box, 
without cutting the bands, to determine the quantity of the insert DNA. 
 
2.5.7. pRW50 EcoRI-HindIII vector preparation 
The pRW50 vector was prepared to be ligated with the previously prepared inserts.  
First, pRW50 was extracted from the E. coli RLG221 strain using QIAfilter Plasmid Maxi 
Kit (QIAGEN). The extraction was performed according to the manufacturer’s 
instructions using the buffers supplied with the kit. Next, 50 l of purified pRW50 was 
mixed with 10 l of CutSmart buffer (NEW ENGLAND BioLabs) and 34 l of H2O. Then, 2 
l of the mixture was removed and deposited into a clean PCR tube and labelled as (A). 
The mixture was then divided into two clean PCR tubes, adding 47 l to each. Next, 3 l 
of EcoRI restriction enzyme was added to the first tube and 3 l of HindIII restriction 
enzyme was added to the other tube. Then, 2 l of each new mixture was transferred 
into two clean PCR tubes and labelled as (B) and (C), respectively. The two mixtures 
were then mixed together and another 2 l was removed and deposited into a fresh PCR 
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tube and labelled as (D). The final mixture and all of the 2 l-samples (A-D) were 
incubated at 37°C for 3 hours to allow the enzymes to cut the pRW50 plasmids at the 
EcoRI and HindIII restriction sites. After the incubation, aliquots A through D were ran 
on a 0.8 % agarose gel to verify that the digestion had worked. After digestion, 4 l of 
CIP (commonly known as CAP; calf alkaline phosphatase) was added to the sample and 
incubated at 37°C for one hour to dephosphorylate the DNA ends. Then, the sample was 
put through the QIAquick PCR Purification Kit (QIAGEN) to remove the enzymes and 
buffer. The DNA was then eluted off the column with 30 l of sterile distilled H2O and 1 
l was run through a gel to check quality and quantity. After verifying that the quality 
and quantity of the DNA was adequate, the vector was ready to be ligated with the insert 
DNA. 
 
2.5.8. Vector-Insert ligation 
The DNA inserts and vector plasmids were cut using EcoRI and HindIII restriction 
enzymes. Therefore, when ligated, the insert would be located between those two 
restriction sites. Three 20 l ligation reactions were prepared in 0.5 ml tubes for each 
promoter sample. One ligation reaction containing the vector plasmid only as a negative 
control and two reactions containing two different concentrations of the insert DNA 
were prepared for each promoter sample. These ligation reactions were set up as shown 
in Table 5. Reaction mixes were then incubated at 16°C overnight. 
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 Reaction 
Component 1 (Control) 2 3 
Vector 0.5 l 0.5 l 0.5 l 
Insert - 0.5 l 1 l (1/50) 
10x buffer 2 l 2 l 2 l 
H2O 17 l 16.5 l 16 l 
T4 DNA 
Ligase 
0.5 l 0.5 l 0.5 l 
Total 20 l 20 l 20 l 
 
 Components of the ligation reactions. 
This table illustrates the components of each ligation reaction prepared to ligate DNA 
inserts into pRW50 vectors. The components shown are for the three different reactions 
prepared for each promoter: one negative control reaction and two reactions containing 
different concentrations of DNA inserts. 
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2.5.9. Transformation 
All ligation reactions (plasmids containing new promoters) were transformed into 
competent cells of a standard lab cloning E. coli strain (M182 in this study). For 
transformation, 20 l of ligated plasmids were mixed with 200 l of competent cells 
(RLG221) and chilled on ice for 60 minutes. A heat shock was introduced by putting the 
samples in a 42°C heat block for 2 minutes and returning them back to ice for five 
minutes. Then, 1 ml of 2x LB media was added and samples were incubated in a 37°C 
shaker for one hour. After that, the samples were centrifuged for 1 minute at full speed 
using a benchtop centrifuge and the supernatant was removed, leaving 100 to 200 l. An 
empty vector (PRW50 with no inserts) was transformed into cells to be used as a 
negative control. Next, the samples were plated onto tetracycline-supplemented 
MacConkey agar plates and incubated at 37oC overnight; growth was checked the next 
day. 
 
2.6.  Plasmid DNA extraction 
All of the plasmids were extracted from the E. coli M182 cells to be sent for sequencing 
as means of confirming successful transformation. Plasmids were extracted using the 
ISOLATE Plasmid Mini Kit (BIOLINE). This was performed according to the 
manufacturer’s instructions and using buffers provided with the kit. 
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2.7.  Sequencing 
Sequencing was performed to confirm that all of the plasmids contained the correct 
promoter sequences. The Functional Genomics and Proteomics Laboratory (University 
of Birmingham, UK) carried out the sequencing. In preparation for sequencing, 7 l of 
the plasmid miniprep was mixed with 3 l of 1 M sequencing primer. Two tubes were 
prepared for each sample. Each tube contained one of the primer pairs. 
 
2.8.  Rubidium chloride-treated competent cells 
E. coli M182 competent cells were prepared for transformation with the plasmids 
constructed in this study containing the newly designed promoters. To prepare 
competent cells, a 5 ml overnight culture of the desired strain was grown. Then, 1 ml of 
the overnight culture was added to 100 ml of drug-free 2x LB and grown with shaking at 
37°C till the OD650 reached approximately 0.5. After that, the 100 ml culture was divided 
into two 50 ml falcon tubes and chilled on ice for 20 minutes. Cells were harvested by 
centrifugation in clinical centrifuge at 4000 rpm for 15 minutes and the supernatant was 
poured off. Each cell pellet was resuspended in 15 ml of TFB I and shaken on ice for 
another 20 minutes. Cells were harvested again and the supernatant was discarded. Cell 
pellets were gently resuspended in 2 ml of TFB II and kept on ice for 30 minutes. 
Aliquots of 100 l were prepared in 1.5 ml eppendorf tubes and kept at -70°C. 
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2.9.  Agarose gel electrophoresis 
Agarose gel electrophoresis was used to verify that the PCR reaction was successful, 
determine the sizes of the DNA fragments against a DNA ladder and assess DNA quality 
and quantity. A 1% agarose gel was prepared by dissolving 1 g of agarose powder in 100 
ml of 0.5x TBE buffer. The mixture was then poured into a specific gel-casting tray and a 
comb was inserted in order to create several wells. Once solidified, the gel was 
transferred to a horizontal electrophoresis tank containing 0.5x TBE buffer. Then, 5 l of 
sample was mixed with 2 l of gel loading dye and the samples were loaded into their 
corresponding wells; a DNA ladder of choice was used to assess fragment size. The run 
was carried out at ~80 to 90 volts to allow clear separation of the ladder bands. 
 
2.10. Promoters used in this study 
Different promoters were used in this study. These promoters were designed to 
demonstrate different strengths to provide gradual decreases/increases in their 
activities and fused to the lac operon. All changes were applied to the -10, extended -10 
and -35 elements. The sequences of these different promoters, from the EcoRI site to the 
-1 base, are shown in Table 6.  
 
2.11. Primers used 
Two sets of qPCR primers were used in this study. The first primer set was designed for 
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Names used in 
present study 
Full name 
Promoter sequence 
Source 
Consensus Consensus 
TTGACA                                      TGnTATAAT 
- 
BKS101 KAB-TTTG 
5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
           EcoRI                                                                                   -5         -1 
Burr et al., 2000 
BKS102 KAB-TTTG-p16G 
5’ GAATTCTAGACAGCTGCATGCATCTGTGTTATGGTTATTTC 3’ 
EcoRI                                                                                   -5         -1 
Burr et al., 2000 
BKS103 KAB-TTTG-p8A-p9A 
5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATAATTATTTC 3’ 
EcoRI                                                                                   -5         -1 
This study 
BKS104 KAB-TTTG-p34T 
5’ GAATTCTTGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
EcoRI                                                                                   -5         -1 
This study 
BKS105 KAB-TTTG-p12C 
5’ GAATTCTAGACAGCTGCATGCATCTTTGTCATGGTTATTTC 3’ 
EcoRI                                                                                   -5         -1 
Chan and busby, 
1989 
BKS106 KAB-TTTG-p14T 
5’ GAATTCTAGACAGCTGCATGCATCTTTTTTATGGTTATTTC 3’ 
EcoRI                                                                                   -5         -1 
This study 
BKS107 KAB-TTTG-p14T-p34T 
5’ GAATTCTTGACAGCTGCATGCATCTTTTTTATGGTTATTTC 3’ 
EcoRI                                                                                   -5         -1 
Chan and busby, 
1989 
BKS108 
KAB-TTTG-p8A-p9A-p16G-
p34T 
5’ GAATTCTTGACAGCTGCATGCATCTGTGTTATAATTATTTC 3’ 
EcoRI                                                                                   -5         -1 
This study 
BKS109 
KAB-TTTG-p8A-p9A-p14T-
p30T-p31G-p32T-p33C 
5’ GAATTCTACTGTGCTGCATGCATCTTTTTTATAATTATTTC 3’ 
EcoRI                                                                                   -5         -1 
This study 
 Sequences of the semisynthetic promoters used in this study. 
This table shows the sequence of all the semisynthetic promoters used in this study (5’3’) from EcoRI to base -1. The -35 elements are 
shown in blue, the extended -10 elements are shown in green (bases -16 and -17) and yellow (bases -14 and -15) and the -10 elements 
are shown in red. The double-underlined base is the base mutated in the starting promoter to obtain the new promoter.
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the first system, which investigated RNAP behavior reflected by different promoters and 
two different regions (lac1357 and lac2720) of the following lacZ gene on pRW50 (Table 
7). The promoter and control probes were named according to the DNA region they 
amplify. However, lac1357 and lac2720 were named according to the distance between 
the transcription start site and the start of the DNA region they bind to.  
The other set of primers was designed to investigate RNAP behavior on the lac operon 
on the chromosome of the E. coli MG1655 strain (Table 8). The lac0 and control A primer 
pairs amplify the promoter region of the lac operon and a silent control region on the 
chromosome, respectively. The lac1, 2, 3, 4 and 5 primer pairs amplify ~300 bp DNA 
sequences located 518, 1421, 2308, 3691 and 4654 base pairs downstream of the 
transcript start, respectively. 
 
2.12. Reporter gene assay 
The promoters’ activities were estimated by measuring β-galactosidase levels as a 
preliminary test (Miller, 1972). This was done to investigate the differences between the 
promoters’ activities according to the differences between the sequences of their 
elements. This experiment was performed in triplicate for each sample: three different 
overnight cultures were prepared for each sample. The next day, 50 l of each of these 
overnight cultures was inoculated into tetracycline-supplemented 5 ml 2x LB media in 
25 ml flasks. The flasks were then incubated at 37°C with shaking until the OD650 
reached 0.3 to 0.6. After that, a drop each of toluene and 1% sodium deoxycholate was
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Primer Code Target Sequence (5’ to 3’) 
D78382DL 
 
Promoter (Fwd) 5’-TCG—CAA—GGA—CGA—GAA—TTT—CC-3’ 
D78383DL 
 
Promoter (Rev) 5’-GTT—TTT—CAG—CAG—GTC—GTT—G-3’ 
D78261DL 
 
lac1357 (Fwd) 5’-GAC—AGT—ATC—GGC—CTC—AGG—AA-3’ 
D78262DL 
 
lac1357 (Rev) 5’-AAC—GTC—GTG—ACT—GGG—AAA—AC-3’ 
D78263 
 
lac2720 (Fwd) 5’-TCT—CTC—CAG—GTA—GCG—AAA—GC-3’ 
D78265DL 
 
lac2720 (Rev) 5’-TAA—TCA—CGA—CGC—GCT—GTA—TC-3’ 
D78254DL 
 
Control A (Fwd) 5’-CAG—TCC—ATC—AGG—TAA—TTG—CCG-3’ 
D78255DL 
 
Control A (Rev) 5’-GCG—CAA—ACT—GTT—AAT—GCT—GG-3’ 
 Probes used in qPCR experiment to measure RNAP flux on the lac operon. 
This table shows the codes, targets and sequences (5’3’) of the probes used to quantify the immunoprecipitated DNA to test 
RNAP flux on the lac operon in pRW50 vectors. 
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Primer code Region Sequence (5’ to 3’) 
D82715BS lac0 (Fwd) 5’-GCG—TTG—GCC—GAT—TCA—TTA—ATG—CAG—C-3’ 
D82716BS lac0 (Rev) 5’-CAA—GGC—GAT—TAA—GTT—GGG—TAA—CGC—CAG-3’ 
D82717BS lac1 (Fwd) 5’-GGT—TAC—GGC—CAG—GAC—AGT—CG-3’ 
D82718BS lac1 (Rev) 5’-CAC—ATC—TGA—ACT—TCA—GCC—TCC—AGT—AC-3’ 
D82719BS lac2 (Fwd) 5’-GAA—TCA—GGC—CAC—GGC—GCT—A-3’ 
D82720BS lac2 (Rev) 5’-AAC—CGC—CAA—GAC—TGT—TAC—CCA—TC-3’ 
D82721BS lac3 (Fwd) 5’-GCA—ATT—TAA—CCG—CCA—GTC—AGG—C-3’ 
D82722BS lac3 (REV) 5’-TGA—TGC—TGC—CAC—GCG—TGA—G-3’ 
D82767BS lac4 (Fwd) 5’-TGC—ACT—CAT—CCT—CGC—CGT—TTT—ACT—C-3’ 
D82768BS lac4 (Rev) 5’-CCA—AAT—ACC—CGC—GTA—CCC—TGT—TC-3’ 
D82725BS lac5 (Fwd) 5’-GTA—GGG—GAA—AAC—GCC—TGG—GTA—G-3’ 
D82726BS lac5 (Rev) 5’-CCA—CAT—GAC—TTC—CGA—TCC—AGA—CG-3’ 
D80465BS Control bglB (Fwd) 5’-GGA—TCA—AGC—CGC—TGG—TAA—CG-3’ 
D80466BS Control bglB (Rev) 5’-CTG—GCA—ACC—AGT—TGA—TGG—TGG—A-3’ 
 Probes used in qPCR experiment to measure RNAP flux on the lac operon on the chromosome. 
This table shows the codes, targets and sequences (5’3’) of the probes used to quantify the immunoprecipitated DNA to test 
RNAP flux on the lac operon on the chromosome. lac0 primer pair probes the promoter region, lac1-5 primer pairs probes the five 
regions to be tested through the lac operon and the bglb primer pair probes a silent control region on the chromosome. 
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added to lyse the cells. Flasks were vigorously shaken and incubated again at 37°C for 20 
minutes with the bung removed. Then, 100 l of lysed cells were added to 2.5 ml of pre-
warmed (37°C) Z buffer containing ONPG at 20 seconds intervals in assay tubes. 
Cultures were watched, and when their colour turned yellow, the reaction was stopped 
by adding 1 ml of Na2CO3 and the time was noted. OD420 measurements were taken for 
all reactions.  
-galactosidase (-gal) activity, for each promoter, was calculated using the following 
equation: 
1000 x 2.5 x 3.6 x OD420 
-gal activity = 
                    OD650 x 4.5 x t x v 
Where: 
2.5 = conversion factor of OD650 into bacterial mass, based on an OD650 of 1 being 
equivalent to 0.4 mg/ml bacteria (dry weight). 
3.6 = final assay volume (ml). 
1000/4.5 = conversion factor of OD420 into nmol o-nitrophenyl (ONP), based on 1 nmol 
ml-1 of ONP having an OD420 of 0.0045. 
t = incubation time (min). 
v = volume of lysate added (ml). 
 
  
 
 
79 
2.13. Chromatin immunoprecipitation 
The general concept of a ChIP experiment is to crosslink proteins to DNA, shear the DNA 
by sonication, pull down specific protein-DNA complexes by using specific antibodies 
and beads, de-crosslink proteins from DNA and purify the resulting DNA. The result of 
these steps is getting DNA fragments that were attached to our protein of interest (i.e., 
RNAP) only. The whole ChIP-qPCR experiment was conducted at least three times for 
each sample as biological repeats. 
 
2.13.1. Cell preparation 
A 5 ml culture of the desired strain was grown in 2x LB media supplemented with 
tetracycline overnight. The OD650 was taken and the amount required to be inoculated in 
40 ml 2x LB to provide a starting OD650 of 0.03 was calculated. Two 40 ml portions of 2x 
LB media containing tetracycline were inoculated with the bacteria and incubated at 
37°C with shaking until the OD650 reached ~0.4. Next, 40 l of rifampicin was added (50 
M final concentration) for 15 minutes to one of the two cultures. However, for 
analysing RNAP flux through the lac operon, the whole ChIP-qPCR experiment was 
performed twice: one time before and after IPTG addition and another time before and 
after rifampicin treatment. 
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2.13.2. Crosslinking 
To crosslink RNAPs to DNA, 1.11 ml of 37% formaldehyde (1% final concentration) was 
added to all cultures and incubated at 37°C with shaking for 20 minutes exactly to avoid 
excessive crosslinking (Grainger et al., 2005; Herring et al., 2005). After that, 5.33 ml of 3 
M glycine (0.5 M final concentration) was added to all cultures and mixed by swirling to 
stop formaldehyde action. Cultures were then immediately transferred to 50 ml falcon 
tubes and cells harvested by centrifugation at 4000 rpm and 4°C for 15 minutes. The 
supernatant was removed from each tube, cells were resuspended in 20 ml of TBS and 
harvested by centrifugation as before. The supernatant was then removed again and the 
cells were resuspended in 1 ml of TBS and transferred to 1.5 ml eppendorf tubes. Next, 
the cells were harvested by centrifugation using a desktop microcentrifuge for 1 minute 
at maximum speed (~13000 rpm). The supernatant was removed, the pellet was 
resuspended in 1 ml of FA lysis buffer containing 4 mg/ml lysozyme and transferred to a 
15 ml falcon tube. The tubes were then incubated at 37°C for 30 minutes and chilled on 
ice for >5 minutes. The cells then were sheared through three rounds of sonication. Each 
round consisted of 10 cycles of 30-second shearing and 30-second resting without 
shearing. Sonication was performed in ice-cold water to obtain the majority of 
fragments in the 300 to 400 bp size range. Then, lysates were cleared by spinning in a 
microcentrifuge for 5 minutes at top speed. After centrifugation, the supernatant 
containing chromatin (~1 ml) was transferred to a 2 ml microfuge tube and diluted in 
FA lysis buffer so that there was 1 ml of lysate for each 20 ml of starting culture (for 40 
ml, dilute chromatin to a total of 2 ml). These tubes were labeled as input chromatin. 
 
  
 
 
81 
2.13.3. Protein A Sepharose (beads) preparation 
Protein A Sepharose (GE Healthcare) beads were washed and a 50% slurry was 
prepared to immunoprecipitate the resulting chromatin. A total of 300 mg of Protein A 
Sepharose beads were washed four times in a 15 ml falcon tube by gently re-suspending 
in 15 ml distilled H2O, slow spinning at 400 rpm for 5 minutes and carefully discarding 
the supernatant. After the fourth wash, the beads were resuspended in an equal amount 
of TBS to achieve a 50% slurry. 
2.13.4. Immunoprecipitation 
The immunoprecipitation reaction was prepared by mixing 500 l of lysate (input 
chromatin), 300 of l FA lysis buffer, 25l of freshly washed 50% slurry beads and 1 l 
of E. coli RNAP beta monoclonal (neoclone) in a clean 1.5 ml eppendorf tube for each 
sample. The lid was securely closed, wrapped with Parafilm and the tubes were rotated 
on a wheel for 90 minutes at room temperature. After 90 minutes of rotation, the beads 
were collected by centrifugation at 3000rpm for 1 minute using a desktop 
microcentrifuge and the supernatant was discarded carefully. The beads were 
resuspended gently in 700 l of FA lysis buffer and transferred to a Spin-X column 
(Costar). The column was then rotated for 3 minutes at room temperature, centrifuged 
at 3000 rpm for 1 minute and the flow-through was discarded. The column was washed 
by adding 750 l of FA lysis buffer, rotating for 3 minutes, centrifuging as before and the 
flow-through was again discarded. The wash step was repeated three times with three 
different buffers: FA lysis buffer 500 mM NaCl, ChIP wash buffer and TE buffer. After 
washing, the Spin-X column was transferred to a clean eppendorf tube, 100 l of ChIP 
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elution buffer was added, the tube was rotated for 3 minutes at room temperature and 
incubated at 65°C for 10 minutes. After incubation, the clean eppendorf tube was 
centrifuged at 3000 rpm for 1 minute, the flow-through was kept and the column was 
discarded. The tubes were then labeled as IP samples. 
 
2.13.5. De-crosslinking 
Crosslinking was reversed by incubating the IP samples at 100°C for 10 minutes 
followed by cooling to 4°C. Then 20 l of the input chromatin was mixed with 80 l of FA 
lysis buffer and de-crosslinked by heating to 100°C for 10 minutes followed by cooling 
to 4°C. After de-crosslinking, the DNA was purified using a QIAquick PCR Purification Kit 
(QIAgen) according to the manufacturer’s instructions and using the buffers supplied 
with the kit. The purified DNA was then eluted in either 50 l of distilled H2O for IP 
samples or 200 l of distilled H2O for input samples. 
2.14. Quantitative Polymerase Chain Reaction 
qPCR was the technique of choice to detect the presence of and quantify copies of DNA 
of interest in our samples after each ChIP experiment. qPCR and conventional PCR share 
the same principle of amplifying DNA following heating and cooling cycles. However, 
using a fluorescent reporter (2x Brilliant III SYBR Green qPCR Master Mix from Agilent 
Technologies in this study) and specific designated primers in qPCR made it easy to 
monitor and quantify the amount of DNA of interest generated in each qPCR cycle 
allowing the comparison of DNA amounts before and after rifampicin treatment in order 
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to calculate occupancies (Wong and Medrano, 2005; VanGuilder et al., 2008; Postollec et 
al., 2011). Each qPCR reaction was prepared by mixing 10 l of 2x Brilliant III SYBR 
Green qPCR Master Mix (Catalogue no. 600882-51), 1 l of each primer, 1 l of DNA after 
the ChIP experiment and 7 l of distilled H2O. The reaction mix was prepared in a 
specific qPCR 96 well plate. The thermal cycling program is shown in Table 9. 
 
2.15. RNAP occupancy unit calculations 
Occupancies were calculated depending on the cycle thresholds (Cts) obtained from the 
qPCR tests for ChIP products. Each qPCR reaction was performed in three technical 
repeats and averages were taken. In each qPCR run, each region occupancy, was 
calibrated against the occupancies obtained from the input DNA (chromatin before 
Immunoprecipitation). Occupancy units were calculated using the comparative CT 
method (Livak and Schmittgen, 2001) based on the following formula: 
Occupancy unit = 2-CT 
Where: 
CT = CT target - CT calibrator 
CT = Average CT target – Average CT control 
Where: 
CT control = CT obtained from the control region 
Calibrator is the input DNA (chromatin) 
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Number of cycles Duration of cycle Temperature 
1 3 minutes 95oC 
35 20 seconds 95oC 
30seconds 56oC 
30 seconds 60oC 
1 1 minute 95oC 
30 seconds 56oC 
30 seconds 95oC 
 Cycling program used for QPCR experiments  
This table shows the number of cycles and the duration and temperature of each qPCR 
cycle. 
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2.16. Calculation of promoter occupancy index 
POI was calculated by calculating the percentage of promoter occupancy before 
rifampicin treatment (measured promoter occupancy) in relation to the promoter 
occupancy after rifampicin treatment (assumed to be 100% occupied) using the 
following equation: 
 
Measured promoter occupancy 
POI =       ---------------------------------------------------------------- X100 
Promoter occupancy after rifampicin treatment 
 
2.17. Calculation of promoter escape index 
EI was calculated by calculating the percentage of downstream region occupancy in 
relation to measured promoter occupancy without rifampicin using the following 
equation: 
Region occupancy by RNAP 
EI =     ----------------------------------------- X100 
Measured promoter occupancy 
 
2.18. Calculation of fragment occupancy percentage 
FOP was calculated by calculating the percentage of the measured fragment occupancy 
from the occupancy after rifampicin treatment of the promoter taken to be 100% 
occupied as follows: 
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      Measured fragment occupancy 
FOP = -------------------------------------------------------------------------------------------------------- 
Occupancy after rifampicin treatment of a promoter taken to be 100% occupied 
 
2.19. Calculation of polymerases per second 
PoPS at a particular gene region was calculated using the following equation: 
1 
PoPS = ------------------------------------------------------------------------------------------ 
Time interval between RNAPs arriving at the start of the region (Tint) 
 
Where: 
Tint = time taken by RNAP to cross the region of interest (seconds) X n 
Where: 
The time taken by RNAP to cross the region 
= length of the region of interest / RNAP speed (taken as 50 bp/second) (Murakawa et 
al., 1991; Vogel and Jensen, 1997). 
 
And 
 
     1 
------ X 100 = percentage of region occupancy to measured promoter occupancy 
     n 
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Chapter 3 
Measurements of RNAP flux through the lac operon on 
the chromosome 
  88 
3.1.  Introduction 
Since its discovery, many aspects of the lac operon have been thoroughly 
studied. These different but related aspects include induction, repression 
(Müller-Hill et al., 1964; Eron and Block, 1971), regulation (Jacob and Monod, 
1961) and even fusions to other genes of interest to understand different 
biological systems (Silhavy and Beckwith, 1985). The lac operon consists of three 
adjacent genes: lacZ, lacY and lacA. As mentioned previously, these genes are 
responsible for lactose metabolism as a source of energy. The full length of the 
lac operon is approximately 5300 bp, including the promoter, operator and 
termination regions (Hediger et al., 1985). The lacZ gene is 3069 bases in length 
and responsible for the production of the -galactosidase enzyme, which breaks 
lactose into glucose and galactose (Kalnins et al., 1983); the lacY gene is 
composed of 1251 nucleotides and responsible for the lactose permease 
production, a membrane enzyme that helps in the lactose uptake (Büchel et al., 
1980); and the lacA gene is 609 bp long and codes for β-galactoside 
transacetylase, which helps in bacterial cell detoxification (Andrews and Lin, 
1976; Hediger et al., 1985). All of these measurements were confirmed by the 
Ecocyc website ("Escherichia Coli K-12 Substr. MG1655 Chromosome: 360,000 - 
370,000"). 
Transcription of the lac operon is negatively controlled by the LacI repressor 
protein. This protein works by binding to one of the three lac operators: 
operator 1 (O1), O2 and O3 (Fulcrand et al., 2013). It has been recently reported 
that, when the LacI repressor protein binds to several O1 operators, it can 
change the topology of the DNA and act as a topological barrier to repress 
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transcription (Leng et al., 2011). Another regulator for the transcription of the 
lac operon is cAMP-receptor protein (CRP). When glucose is absent and lactose is 
present, CRP becomes activated by cyclic adenosine monophosphate (cAMP) and 
activates the transcription of the lac operon. 
Many previous studies have attempted to measure RNAP flux, velocity and 
distribution on bacterial operons. In 1998, a study was carried out to address 
RNAP speed, while progressing along a DNA fragment, under different regimes of 
force load applied by an optical trap (Wang et al., 1998). Another study, in an 
attempt to address the regulation of RNA synthesis in E. coli, compared the 
growth rate of ribosomal and messenger RNA (mRNA) chains synthesized by 
RNAP. In this study, it can be assumed that the growth rate reflects RNAP speed 
(Dennis and Bremer, 1973). A different study calculated the number of RNAPs on 
the lac operon by calculating the rate of RNA synthesis (Kennel and Riezman, 
1977). The researchers compared this number with the same number obtained 
from ribosomal RNA synthesis. They claimed that, in the lac operon, RNAP 
transcribes 40 nucleotides per second, but this rate increases to 80 nucleotides 
per second with the ribosomal RNA (rRNA) genes. Condon and colleagues 
mentioned the same increase in elongation rate between synthesizing mRNA and 
rRNA chains (Condon et al., 1995). 
The lac operon is one of the most extensively characterized operons in terms of 
function, transcription and regulation, making it a model system for bacterial 
genome studies. In this portion of the current study, I attempted to apply my 
newly developed method to directly measure RNAP flux through the lac operon. 
As previously mentioned, transcription of the lac operon can be triggered by 
IPTG, which overcomes the LacI repression. This phenomenon allowed for easy 
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induction of lac operon transcription in this part of the study, which was 
performed to analyze RNAP flux through the lac operon on the chromosome 
using a ChIP–qPCR experiment and several probes to apply this new and direct 
method to specific fragments of the lac operon. 
3.2. Method 
To summarize, RNAP was crosslinked to bound DNA targets as a result of 
formaldehyde treatment of ~0.4 OD650 E. coli cultures. After crosslinking, DNA 
was then sheared by sonication and immunoprecipitated using mice monoclonal 
antibodies against the RNAP β subunit. These pulled down targets were then 
quantified using qPCR. In this study, we used the well-studied E. coli K-12 lac 
operon, which is controlled by a promoter whose activity is repressed by the Lac 
repressor protein (LacI). Transcription of this operon was induced by IPTG. 
Seven pairs of probes were designed to analyze RNAP flux through the lac 
operon. One of these pairs of probes (lac0) was designed to sample the lac 
promoter region and another one (bglB) was designed to sample a control 
region. The lac1-5 pairs of probes were designed to sample five different DNA 
sequences that are 518, 1421, 2308, 3691 and 4654 bp, respectively, 
downstream from the transcription start site (Figure 9). All seven pairs of probes 
were designed to sample ~300 bp fragments, allowing the direct comparison of 
the signals obtained from different probes. Then, the ChIP-qPCR experiment was 
applied to E. coli strain MG1655, growing to an OD650 of ~0.4. This experiment 
was applied twice to the lac operon. The first time was to test RNAP flux in 
IPTG-induced cells versus non-induced cells. This was performed to ensure that 
the Lac repressor regulates transcription of the lac operon and all signals seen in 
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Figure 9. Approximate locations of the lac0-5 probes. 
This figure shows the approximate locations of the lac0-5 primer pairs used to 
probe the five immunoprecipitated target regions of the lac operon on the 
chromosome. 
 
 
 
 
 
  lacZ lacY lacA 
lac0 lac1 lac2 lac3 lac4 lac5 
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both experiments are due to RNAP genuinely transcribing, and not due to other 
crosslinked components or proteins, as they are not seen in the control 
experiments performed without IPTG induction. 
 In the second instance, the same experiment was done but to test 
rifampicin-treated cells against non-rifampicin-treated cells where both cultures 
were treated with 100 M IPTG to induce the lac expression. 
3.3.  Optimisation of the method 
3.3.1. Rifampicin treatment time optimisation: 
As weak promoters will not be as competitive as strong ones in recruiting RNAP, the 
15 minutes rifampicin treatment time was tested for the weakest promoter in my 
promoters’ hierarchy (BKS105). This will insure that the 15 minutes rifampicin 
treatment is enough for even weak promoters to be fully occupied with RNAP after 
rifampicin treatment. This test was carried out by growing the cells in five 40 ml 2x 
LB cultures to an OD650 of ~0.4. These five cultures were treated with rifampicin at a 
final concentration of 50 M and incubated with shaking at 37oC. After that, 
formaldehyde was added to each culture at a time interval of five minutes, so the five 
cultures will be treated with rifampicin for 5, 10, 15, 20 and 25 minutes. The rest of 
the ChIP-qPCR experiment was performed normally to all cultures and promoter 
occupancy of each sample was calculated. The final result of this test confirmed that 
15 minutes treatment of rifampicin was enough to block all recruited RNAPs at 
promoters by showing that promoter occupancy level gradually increased after 5, 10 
and 15 minutes rifampicin treatment, however, this gradual increase did not 
continue with the samples treated for 20 and 25 minutes. 
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3.3.2. Sonication time optimisation: 
This part of the experiment was mainly performed by Dr. Jack Bryant to ensure that 
the sonication time is suitable to produce the DNA fragments within the desired 
range of lengths (~300 – 700 bp). Six 1 ml lysates were processed in the Bioruptor 
sonicator and removed at six cycle numbers (10, 20, 25, 28, 30 and 32 cycle 
numbers). Sonication was carried out by putting 250 ml beaker of ice in the water 
bath then the bath filled with cold (4oC) water to the line. After that, samples were 
applied and sonication was started on HIGH for 10 cycles of 30 seconds ON / 30 
seconds OFF. Then, water and ice were replaced with fresh cold ones, as they will 
have heated up. These sonication steps were repeated three times and reflector bars 
were cleaned with 70% ethanol in the end. After sonication, samples were spun 
down, decrosslinked, purified using a QIAquick PCR Purification Kit (QIAgen) 
according to the manufacturer’s instructions and concentrated using SpeedVac 
concentrator. After that, samples were run on agarose gel to test fragments sizes in 
comparison to 100 bp ladder loaded in a separate well on the same gel. This 
experiment suggested that 30 cycles of sonication were best to achieve DNA 
fragments within the desired length range. 
 
3.4.  Measurement of RNAP flux through the lac operon 
before and after induction 
The ChIP–qPCR method was applied to the E. coli K-12 lac operon, with and 
without IPTG induction, to address the flux of RNAP through this operon. IPTG 
was added to a final concentration of 100 M. The data obtained showed that 
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there was a >10-fold increase in levels of immunoprecipitated DNA after the 
addition of IPTG (Figure 10). This confirms that the Lac repressor regulates lac 
operon transcription. Recalling that, in this method, the amount of 
immunoprecipitated DNA reflects the amount of RNAP bound to the DNA in each 
immunoprecipitated fragment, RNAP levels were similar for approximately the 
first 2000 bp of the lac operon and then declined towards its end. This decline 
probably resulted from polarity effects. Furthermore, some fragments, such as 
lac3, showed an increase in the amount of immunoprecipitated DNA. This 
increase was likely due to some sort of pause sequences (Larson et al., 2014; 
Vvedenskaya et al., 2014). After this high amount of immunoprecipitated DNA in 
the lac3 fragment, there was a sizeable decline in fragments lac4 and lac5. This 
decline may be explained by a previous study that investigated a rho-dependent 
terminator in the intergenic space between the lacZ and lacY genes. However, the 
findings of the study claimed that this terminator is not effective in cells growing 
in normal conditions (Murakawa et al., 1991). 
 
3.5.  Measurement of RNAP flux through the lac operon 
before and after rifampicin treatment 
The same experiment was applied again to E. coli strain MG1655 under the same 
conditions, but this time the rifampicin property of blocking RNAPs at promoters 
was exploited (Grainger et al., 2005). Trapping RNAPs at promoters means that 
each promoter is occupied by a single RNAP. Carrying out the ChIP-qPCR 
experiment, with and without rifampicin treatment, after IPTG induction, 
allowed for the calculation of the absolute numbers of RNAPs bound to each
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Figure 10. RNAP flux on the lac operon on the chromosome before 
and after IPTG treatment. 
This figure shows the RNAP flux on the lac operon on the chromosome before 
(blue bars) and after (red bars) 100 M IPTG treatment. 
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immunoprecipitated fragment of the lac operon. Figure 11 shows quantification 
of immunoprecipitated DNA corresponding to the lac0 pair of probes was 
increased after rifampicin treatment but significantly decreased corresponding 
to the lac1-5 probes. These data also permitted the calculation of the promoter 
occupancy index (POI) for the promoter region, the promoter’s escape index (EI), 
fragment occupancy percentage (FOP), the average time interval between RNAPs 
(Tint) and how many RNAPs are passing through each fragment in one second 
(polymerases per second; PoPS). 
As each promoter is occupied by one RNAP after IPTG induction and rifampicin 
treatment, an assumption can be made that, the promoter is 100% occupied and 
the POI is ~47.6% ((56.5/118.7) x 100); this signifies that the promoter is 
approximately 47.6% occupied. This promoter showed an EI value of 
approximately 67% ((38/56.5) x 100). For the lac1 region, the occupancy value 
was 38 units, which is ~32% ((38/118.7) x 100) i.e., 1/3.1 of the promoter full 
occupancy after rifampicin treatment. As RNAP takes roughly 6 seconds to 
traverse each region (300 bp/50 bp per second), the Tint for this region was 18.6 
seconds (6 x 3.1) and PoPS for this region was 0.053 (1/18.6). The same 
calculations were applied to the other regions and all values are shown in Table 
10. 
 
3.6.  Discussion 
The lac operon consists of three adjacent genes with related functions: lacZ, lacY 
and lacA. These genes are responsible for lactose transport and metabolism in 
many bacteria, including E. coli. Expression of the lacZ gene allows for the
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Figure 11. RNAP flux on the lac operon on the chromosome before 
and after rifampicin treatment. 
This figure shows the RNAP flux on the lac operon on the chromosome with 100 
M IPTG treatment (blue bars) and with 100 M IPTG + 50 M rifampicin 
treatment (red bars). 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
lac0    56.5 47.6 - - 
lac1 38 32 18.6 0.053 
lac2 42.5 35.8 16.8 0.059 
lac3 72.5 61 9.6 0.1 
lac4 20 16.8 36 0.027 
lac5 14 11.8 51 0.019 
 
 Occupancy values and percentages, Tint and PoPS values for 
the lac operon on the chromosome before and after rifampicin 
treatment. 
This table illustrates the occupancy values, fragment occupancy percentages 
(FOP), Tint and PoPS values for the lac0-5 regions of the lac operon on the 
chromosome before and after 50 M rifampicin treatment. 
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production of the -galactosidase enzyme, which breaks down lactose into 
glucose and galactose. Similarly, lacY expression produces a membrane protein 
called the lactose permease, which is responsible for lactose transportation into 
the cell (Halasz et al., 2007). Finally, the lacA gene encodes for the production of 
the transacetylase enzyme, which helps in cellular detoxification (Andrews and 
Lin, 1976). The lac system has been thoroughly studied over the last few decades 
and has become a model system for bacterial biological systems including gene 
expression and regulation. 
In this study, a new method was successfully developed to measure RNAP flux 
through bacterial operons. In this chapter, this method was applied to study 
RNAP flux through five regions along the well-characterized E. coli lac operon. 
We firstly applied the new method on the lac operon before and after IPTG 
treatment. Then, the same method was applied to IPTG-induced cultures but 
before and after rifampicin treatment. 
More than a 100-fold increase in the amount of immunoprecipitated DNA was 
recorded after IPTG treatment from the induced versus non-induced cells. This 
increase confirms that the Lac repressor regulates transcription of the lac 
operon. 
The results obtained from the second experiment measuring POI depending on 
occupancy with and without rifampicin treatment showed that the lac promoter 
was ~47.6% occupied. This confirms the findings of previous studies showing 
that the lac promoter in E. coli is limited by RNAP recruitment (Malan et al., 
1984; Buckle et al., 1991). This phenomenon might be explained by the fact that 
the expression of the lac operon depends on recruitment of RNAP to the 
promoter, and this depends on the local concentration of free RNAP. This 
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dependency was shown in a previous study that tested the expression of the lac 
promoter::gfp fusion in different positions on the chromosome; the findings 
demonstrated different expression rates in different locations on the 
chromosome (Bryant et al., 2014). This promoter also showed a low EI of 
approximately 67%, and there is roughly a 18.6-second gap between RNAPs 
escaping the promoter to the nearest tested region (lac1). This finding supports 
previous studies claiming that the promoter escape step is complex and may take 
some time (Chander et al., 2015; Bauer et al., 2016). Several explanations were 
suggested for promoter clearance delays involving abortive transcription 
initiation during DNA scrunching (Revyakin et al., 2006) and 70-dependent 
transcription pausing (Strobel and Roberts, 2015). 
The tested downstream fragments (lac1–lac5) showed different occupancy 
percentages, ranging from 11.8% in lac5 to 61% in lac3. These ranging 
occupancy percentages indicate that, during transcription elongation, RNAPs are 
not evenly spread through the lac operon, most likely because of pause 
sequences (Larson et al., 2014; Vvedenskaya et al., 2014). Furthermore, the 
occupancy percentage of each fragment is inversely proportional to the time gap 
between RNAPs appearing at the start of the same region (Tint) and parallel to 
PoPS value of the same region. For instance, the lac5 region has the lowest 
occupancy percentage of 11.8%, the longest Tint value of 51 seconds and the 
lowest PoPS value of 0.019. Similarly, the lac3 region has the highest occupancy 
percentage of 61%, the shortest Tint value of 9.6 seconds and the highest PoPS 
value of 0.1. As a result of polarity effects, signals obtained from lacY and lacA 
genes are less than those obtained from lacZ gene reflecting less transcripts and 
  101 
less final products. This finding concurs with the findings of Grainger and his 
coworkers in 2005 (Grainger et al., 2005). 
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Chapter 4 
Manipulating the sequences of promoter 
elements affects RNAP recruitment and escape in 
different ways 
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4.1.  Introduction 
For DNA-dependent RNAP to transcribe specific genes, it initially needs to bind 
to specific regions of the DNA located directly before a gene’s transcription start 
site known as promoters (Shultzaberger et al., 2007). These promoters play an 
important role in transcription as they recruit DNA-dependent RNAP for the 
transcription of their corresponding genes. Each promoter has four conserved 
elements that are recognized by the RNAP holoenzyme: the -10, 
extended -10, -35 and UP elements (Busby and Savery, 2007; Mekler et al., 
2012). Promoter conserved elements are the main determinant of RNAP 
specificity to promoters. A promoter’s activity or “strength” is often connected to 
its ability to recruit RNAPs (i.e., the stronger the promoter, the higher the affinity 
to RNAPs). This affinity is mainly determined by the sequences of the promoter’s 
conserved elements mentioned above (i.e., the closer the sequence to the 
consensus, the higher the affinity to RNAPs) (Phan et al., 2012). In this study, the 
sequences of three promoter elements were manipulated to achieve a gradual 
increase/decrease in promoter activity. These promoters (Table 6, page 74) 
were then inserted into the pRW50 plasmid in the K-12 E. coli M182 strain just 
before the well-characterized lac operon. In this part of the study, I used the first 
lac gene (lacZ) to test different transcriptional activities associated with the 
designed semisynthetic promoters. 
The starting promoter was BKS101, which is a galp1 derivative: a fairly active 
promoter with a good -35 element holding a sequence of 5’ TAGACA 3’ 
(consensus is 5’ TTGACA 3’), a fairly good extended -10 element with a sequence 
of 5’ TTTG 3’ (consensus is 5’ TGTG 3’) and a good -10 element with a sequence 
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of 5’ TATGGT 3’ (consensus is 5’ TATAAT 3’) (Table 11). The promoter sequence 
was successively manipulated to build a set of promoters with a gradual range of 
activity ranging from very high to very low. In some promoters, the sequence of 
each promoter element was changed separately to fully ascertain the effect of 
each change on the transcription process. Other promoters had two or even 
three mutations to expand the range of activity between promoters and get them 
closer to or more distant from consensus promoter sequences. Note that 
promoters of equal strengths can be built by combinations of different sequence 
elements. 
The promoters’ activities were firstly assessed using a reporter gene assay 
estimating promoter activity by measuring -galactosidase levels of the lacZ 
gene of each promoter. Then, the ChIP-qPCR method was applied to get a clear 
and direct (as in the cells) view of transcriptional behavior, such as POI and 
RNAP flux in the corresponding gene, EI, promoter competitivity or FOP, 
associated with each promoter. POI was estimated by calculating the percentage 
of promoter occupancy in relation to the full occupancy state of the promoter 
assumed to be 100% occupied after rifampicin treatment. Promoter 
competitivity was calculated from the percentage of promoter occupancy after 
rifampicin treatment in relation to the measured occupancy after rifampicin 
treatment of a strong promoter taken to be 100% occupied. FOP was estimated 
by calculating the percentage of any downstream fragment occupancy in relation 
to the full occupancy state of a strong promoter taken to be 100% occupied after 
rifampicin treatment. However, EI was estimated by calculating the percentage 
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Promoter Sequence 
BKS101 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
 
 Starting promoter BKS101 sequence from the EcoR1 site to 
the -1 base. 
This table shows the sequence of our starting promoter BKS101 (5’3’) from 
the EcoR1 site to base -1. The -35 element is shown in blue, the extended -10 
element is shown in green (bases -16 and -17) and yellow (bases -14 and -15) 
and the -10 element is shown in red. Note that all promoter sequences are shown 
in table 6 (page 74). 
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of RNAP occupancy in the lac1357 region (the number is the distance between 
the transcription start site and the start of this region) in relation to the 
promoter occupancy before rifampicin treatment. Being able to calculate the 
occupancies of the promoter and two downstream regions (lac1357 and 
lac2720), shown in figure 8 (page 54), allowed the calculation of RNAP flux 
through each region of the gene, which is represented as PoPS. From now on, 
promoter occupancy before rifampicin treatment will be referred to as 
“measured promoter occupancy”, and promoter occupancy after rifampicin 
treatment will be referred to as “promoter full occupancy”. 
 
4.2. Reporter gene assay 
A reporter gene assay was used in this study to primarily assess the strengths of 
all promoters in vitro prior to the ChIP-qPCR method. -galactosidase is the final 
product of the lacZ gene, which is activated by our set of promoters. Depending 
on each promoter’s activity, the lacZ gene produces -galactosidase. In other 
words, the stronger the promoter, the higher the -galactosidase level observed. 
All promoters showed different levels of -galactosidase, ranging from ~30 
miller units for weak promoters to ~4000 miller units for strong promoters. An 
empty vector with no promoter inserted was used as a negative control. The 
different -galactosidase activities including the negative control are shown in 
Figure 12.             mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm
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Figure 12. -galactosidase measured activities for all 9 promoters used in this study. 
This bar chart illustrates -galactosidase activities of the E. coli M182 strain carrying the pRW50 plasmid with the 9 promoters used in this study, 
shown in the X axis, from highest to lowest activity in Miller units. The “No Insert” sample represents the E. coli M182 strain carrying the pRW50 
plasmid with no promoter inserted as a negative control. Measurements were taken after growing the samples in 2x LB media at 37°C to an OD650 of 
0.5. These values are the averages of at least three independent assays. The error bars on each bar show the standard deviation for each reading. 
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4.3. Effect of improving extended -10 element on 
promoter activity 
To address the impact of improving the extended -10 element of the BKS101 
promoter on its activity, another promoter carrying a p16G point mutation 
(promoter BKS102) changing the extended -10 element sequence from 
5’ TTTG 3’ to the consensus sequence of 5’ TGTG 3’ was designed (Table 12). 
Unsurprisingly, this mutation has greatly induced overall promoter activity as 
measured by reporter gene assay. This activity was almost doubled from 
2322.342 units in promoter BKS101 to 4063.3 units in promoter BKS102 (Figure 
12). 
Likewise, our new suggested direct method showed that improving the 
extended -10 element doubled the overall activity of the promoter (Figure 13). 
The promoter significantly improved in recruiting RNAP, showing a dramatic 
increase in POI level from 42.1% ((25.7/61.1) x 100) with promoter BKS101 to 
approximately 91.3% ((54.8/60) x 100) with the altered promoter BKS102. Both 
promoters were assumed to be 100% occupied after rifampicin treatment and 
the promoter competitivity was the same in both promoters showing a value of 
100%. However, by comparing EI of both promoters, it is clear that this mutation 
has no major effect on the RNAP escape rate. The EI only increased by ~7% from 
34.2% ((8.8/25.7) x 100) to 41.1% ((22.5/54.8) x 100). -galactosidase levels, 
POI and EI values are shown in Table 13. 
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Promoter Sequence 
BKS101   5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
BKS102 5’ GAATTCTAGACAGCTGCATGCATCTGTGTTATGGTTATTTC 3’ 
 
 Sequences of promoters BKS101 and BKS102. 
This table shows the sequences of the BKS101 and BKS102 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the extended 
-10 elements are shown in green (bases -16 and -17) and yellow (bases -14 
and -15) and the -10 elements are shown in red. The double-underlined base is 
the base mutated in the starting promoter to obtain the new promoter. 
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Figure 13. RNAP occupancies of promoters BKS101 and BKS102. 
These two bar charts show RNAP occupancies of BKS101 (upper chart) and 
BKS102 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS101 2322.342 100 42.1% 34.2% 
BKS102 4063.302 100 91.3% 41.1% 
 
 -galactosidase levels, POI and EI values of promoters BKS101 
and BKS102. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS101 and BKS102 promoters. 
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PoPS was also calculated for the lac1357 and lac2720 regions following both 
promoters depending on the occupancy values of the promoter before and after 
rifampicin treatment and the measured occupancy values of both downstream 
regions. However, promoter occupancy after rifampicin treatment for both 
promoters was considered to be 100% to calculate the percentage of RNAP in 
downstream regions. The lac1357 and lac2720 regions are approximately 
300 bp long. Therefore, considering the fact that RNAP travels at a rate of 50 
bp/second, it takes RNAP 6 seconds to cross each region. 
For promoter BKS101, the measured occupancy values for promoter, lac1357 
and lac2720 were 25.7, 8.8 and 5.2, respectively. Therefore, the FOP of lac1357 
region is 14.4% ((8.8/61.1) x 100) so, the region is 1/6.94 of the time occupied. 
Accordingly, the time interval between RNAPs (Tint) crossing this region is 41.6 
seconds (6 x 6.94). Therefore, PoPS for this region is 0.024 (1/41.6). Similarly, 
the FOP of lac2720 region was 8.5% ((5.2/61.1) x 100) so the region is 1/11.76 
of the time occupied. Thus, Tint is 70.6 seconds (6 x 11.76) and the PoPS value is 
0.014 (1/70.6). All these values for promoter BKS101 are illustrated in Table 14. 
The same calculations were applied to promoter BKS102 to investigate the FOP, 
Tint and PoPS values after improving the extended -10 element of promoter 
BKS101. The FOP for the lac1357 region of this promoter was 37.5 (1/2.67 of the 
time occupied). Thus, Tint is 16 (6 x 2.67) and PoPS is 0.06 (1/16). For the 
lac2720 region, FOP was 20.7 (1/4.83 of the time occupied). Therefore, Tint for 
this region is 29 (6 x 4.83) and PoPS was 0.034 (1/29). These values are shown 
in Table 15. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter 
BKS101 
25.7 - - - 
Lac1357 8.8 14.4 41.6 0.024 
Lac2720 5.2 8.5 70.6 0.014 
 
  PoPS for promoter BKS101. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS101 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter 
BKS102 
54.8 - - - 
Lac1357 22.5 37.5 16 0.06 
Lac2720 12.4 20.7 29 0.034 
 
  PoPS for promoter BKS102. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS102 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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4.4. Effect of downgrading the extended -10 element on 
promoter activity 
The effect of downgrading the extended -10 element of the promoter was tested 
by introducing a p14T to promoter BKS101 to get promoter BKS106. This 
mutation altered the extended -10 element sequence from 5’ TTTG 3’ to 
5’ TTTT 3’ as shown in Table 16. The activity of this newly designed promoter 
was assessed using a reporter gene assay to measure the -galactosidase levels 
of this promoter. Predictably, the promoter showed a great decrease in activity 
when compared with the original BKS101 promoter. The -galactosidase level 
has significantly dropped from 2322.3 in promoter BKS101 to 31.8 in this new 
promoter (Figure 12). 
This drop in activity was also confirmed by the ChIP-qPCR method. The 
measured promoter occupancy also dropped to 0.52 units from 25.7 units in the 
original promoter (Figure 14). Considering these occupancy values and 
promoters’ full occupancy values, promoter competitivity, POI and EI were 
calculated for this promoter. Promoter competitivity sharply dropped from 
100% units with promoter BKS101 to 3.24% with the mutated promoter. The 
POI value also dropped from 42.1% with the original promoter to 0.85% with 
the mutated promoter. The EI level showed that RNAP escaped the mutated 
promoter more easily than the original promoter, increasing from 34.2% to 
65.4% as shown in Table 17. 
Like previous promoters, PoPS was calculated for this promoter depending on 
the occupancy values obtained from the ChIP-qPCR experiment. These
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Promoter Sequence 
BKS101 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
BKS106 5’ GAATTCTAGACAGCTGCATGCATCTTTTTTATGGTTATTTC 3’ 
 
  Sequences of promoters BKS101 and BKS106. 
This table shows the sequences of the BKS101 and BKS106 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the 
extended -10 elements are shown in green (bases -16 and -17) and yellow (bases 
-14 and -15) and the -10 elements are shown in red. The double-underlined base 
is the base mutated in the starting promoter to obtain the new promoter. 
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Figure 14. RNAP occupancies of promoters BKS101 and BKS106. 
These two bar charts show RNAP occupancies of BKS101 (upper chart) and 
BKS106 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS101 2322.342 100 42.1% 34.2% 
BKS106 31.8 3.24 0.85% 65.4% 
 
 -galactosidase levels, POI and EI values of promoters BKS101 
and BKS106. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS101 and BKS106 promoters. 
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occupancy values were 0.52 units for the promoter region, 0.34 for the lac1357 
region and 0.2 for the lac2720 region of the lacZ gene following the promoter. 
Therefore, the percentage of lac1357 occupancy to promoter BKS101 full 
occupancy state, after rifampicin treatment, was 0.56% (1/178.6 of the time 
occupied) and Tint was calculated by multiplying the time taken by RNAP to 
transverse the 300 bp region by 178.6 (6 x 178.6), resulting in 1071.6 seconds. 
Hence PoPS for this region was 0.0009 (1/1071.6). PoPS was calculated for 
thelac2720 region following the same method. The percentage of lac2720 
occupancy to promoter BKS101 full occupancy state was 0.33 (1/303 of the time 
occupied). Accordingly, Tint for this region was 1818 seconds (6 x 303) and PoPS 
was 0.0005 (Table 18). 
 
4.5. Effect of improving -35 element on promoter 
activity 
The ChIP-qPCR experiment was repeated using a derivative of the promoter 
BKS101 having a consensus -35 element (promoter BKS104). The mutation 
targeted base -34 in particular converting the -35 element sequence from 
5’ TAGACA 3’ to 5’ TTGACA 3’ and yielding a promoter with a perfect 
consensus -35 element, good -10 and extended -10 elements (Table 19). Against 
all expectations, this mutation almost completely disrupted the overall promoter 
activity, even though there was a consensus -35 element. The reporter gene 
assay showed that the overall activity decreased markedly from 2322.3 to 64.85 
with this promoter (Figure 12). This unexplained decrease was confirmed via 
ChIP-qPCR method as well. Promoter competitivity was only 6.92% (Figure 15).
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS106 
0.52 - - - 
lac1357 0.34 0.56 1071.6 0.0009 
lac2720 0.2 0.33 1818 0.0005 
 
  PoPS for promoter BKS106. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS106 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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Promoter Sequence 
BKS101 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
BKS104 5’ GAATTCTTGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
 
  Sequences of promoters BKS101 and BKS104. 
This table shows the sequences of the BKS101 and BKS104 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the extended 
-10 elements are shown in green (bases -16 and -17) and yellow (bases -14 and -
15) and the -10 elements are shown in red. The double-underlined base is the 
base mutated in the starting promoter to obtain the new promoter. 
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Figure 15. RNAP occupancies of promoters BKS101 and BKS104. 
These two bar charts show RNAP occupancies of BKS101 (upper chart) and 
BKS104 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Against all expectations improving the -35 element negatively affected POI level, 
which decreased from 42.1% in promoter BKS101 to 3.86% in this promoter. 
Conversely, EI increased from 34.2% to 45.8% (Table 20). 
The same method of PoPS calculation was applied to promoter BKS104. 
Measured occupancy values for the promoter, lac1357 and lac2720 were first 
calculated. These values were 2.36 for the promoter region, 1.08 for the lac1357 
region and 0.94 for the lac2720 region. Therefore, the FOP of lac1357 region was 
1.8% (1/55.55 of the time occupied). Accordingly, the Tint was 333.3 seconds (6 x 
55.55). Therefore, PoPS for this region was 0.003 (1/333.3). The same 
calculations can be applied to the lac2720 region of this promoter. The FOP of 
lac2720 region was 1.54% (1/64.9 of the time occupied). Thus, Tint was 389.4 
seconds and the PoPS value was 0.0026 (1/389.4). All these values for promoter 
BKS104 are illustrated in Table 21. 
 
4.6. Effect of downgrading -10 element on promoter 
activity 
To test the effect of downgrading the -10 element of promoter BKS101, a single 
mutation was introduced to base -12 of the promoter, changing it from T to C. 
This mutation resulted in a promoter (BKS105) with good -35 and extended -10 
elements and a corrupted -10 element, which was changed from 5’ TATGGT 3’ to 
5’ CATGGT 3’ (Table 22). As expected, corrupting the -10 element led to a 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS101 2322.342 100 42.1% 34.2% 
BKS104 64.85 6.92 3.86% 45.8% 
 
 -galactosidase levels, POI and EI values of promoters BKS101 
and BKS104. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS101 and BKS104 promoters. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS104 
2.36 - - - 
lac1357 1.08 1.8 333.3 0.003 
lac2720 0.94 1.54 389.4 0.0026 
 
  PoPS for promoter BKS104. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS104 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
 
 
 
 
 
 
 
 
  126 
 
 
 
 
 
 
 
 
 
Promoter Sequence 
BKS101 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
BKS105 5’ GAATTCTAGACAGCTGCATGCATCTTTGTCATGGTTATTTC 3’ 
 
 Sequences of promoters BKS101 and BKS105. 
This table shows the sequences of the BKS101 and BKS105 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the 
extended -10 elements are shown in green (bases -16 and -17) and yellow 
(bases -14 and -15) and the -10 elements are shown in red. The double-
underlined base is the base mutated in the starting promoter to obtain the new 
promoter. 
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dramatic drop in promoter strength. The -galactosidase level measured with 
the reporter gene assay dropped from 2322.3 units to around 30 units with this 
altered promoter (Figure 12). 
To have a clear view of how this change affected transcription, the ChIP-qPCR 
method was applied afterwards on this promoter (BKS105). ChIP-qPCR results 
agreed with reporter gene assay results showing a great decrease in overall 
promoter activity. Promoter competitivity dropped to 12.4% after altering 
the -10 element. Measured promoter occupancy also dropped from 25.7 units to 
0.93 units (Figure 16). The POI value dropped from 42.1% with promoter 
BKS101 to 1.52% with this promoter. However, the EI value greatly increased 
from 34.2% to 86%, showing that this new promoter let RNAP escape easily 
(Table 23). 
PoPS was also calculated for the lac1357 and lac2720 regions of the BKS105 
promoter::lac fusion considering the occupancy values of these two regions and 
the promoter BKS101 full occupancy state. Measured promoter occupancy was 
0.93 units, lac1357 region occupancy was 0.8 units and lac2720 region 
occupancy was 0.64 units. For the lac1357 region, the FOP was 1.3% (1/76.9 of 
the time occupied). Therefore, Tint for this region was 461.4 (6 x 76.9) seconds 
and PoPS was 0.0022 (1/461.4). The same was applied to the lac2720 region. 
The FOP was 1.05% (1/95.2 of the time occupied) and the Tint was calculated by 
multiplying the time taken by RNAP to cross the region (6 seconds) by 95.2, 
resulting in 571.2 seconds. PoPS was calculated by dividing 1 by the time interval 
between RNAPs arriving at the start of this region (1/571.2), resulting in 0.0017 
polymerase per second. These values are illustrated in Table 24. 
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Figure 16. RNAP occupancies of promoters BKS101 and BKS105. 
These two bar charts show RNAP occupancies of BKS101 (upper chart) and 
BKS105 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS101 2322.342 100 42.1% 34.2% 
BKS105 30.05 12.4 1.52% 86% 
 
  -galactosidase levels, POI and EI values of promoters 
BKS101 and BKS105. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS101 and BKS105 promoters. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS105 
0.93 - - - 
lac1357 0.8 1.3 461.4 0.0022 
lac2720 0.64 1.05  571.2 0.0017 
 
 PoPS for promoter BKS105. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS105 promoter::lac fusion. It also shows the time 
interval taken by RNAP to cross the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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4.7. Effect of improving the -35 element of a promoter 
having a corrupted extended -10 element 
In this scenario, promoter BKS106 was used as a template to introduce a single 
mutation to the -35 promoter element in order to have a promoter containing a 
consensus -35, corrupted extended -10 and a good -10 element (BKS107). This 
mutation targeted the -34 base of the -35 element, changing it from A to T. 
Therefore, the -35 element sequence was changed from 5’ TAGACA 3’ to 
5’ TTGACA 3’ as shown in Table 25. 
The effect of this change was first addressed by assaying the lacZ gene final 
product (-galactosidase). As expected, having a consensus -35 element revived 
promoter strength. The -galactosidase level significantly increased from 31.8 
units with promoter BKS106 to 1479.6 units with this promoter (Figure 12). 
Promoter occupancy values, calculated from the ChIP-qPCR experiment before 
and after rifampicin treatment, agreed with the reporter gene assay showing that 
this mutation positively affected promoter strength. After rifampicin treatment, 
this new promoter showed a full occupancy of 66.3 units with 100% 
competitivity, whereas it was 1.98 units with 3.24% competitivity in promoter 
BKS106. Promoter occupancy under normal conditions also increased from 0.52 
units with promoter BKS106 to 18 units with this promoter. All of these changes 
are shown in Figure 17. POI and EI values were calculated considering the 
occupancies of the promoter and a downstream region of the lacZ gene as before. 
The POI greatly increased from 0.85% to 27.2%. The EI value decreased with this 
promoter from 65.4% to 24.4% (Table 26). 
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Promoter Sequence 
BKS106 5’ GAATTCTAGACAGCTGCATGCATCTTTTTTATGGTTATTTC 3’ 
BKS107 5’ GAATTCTTGACAGCTGCATGCATCTTTTTTATGGTTATTTC 3’ 
 
  Sequences of promoters BKS106 and BKS107. 
This table shows the sequences of the BKS106 and BKS107 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the extended 
-10 elements are shown in green (bases -16 and -17) and yellow (bases -14 and -
15) and the -10 elements are shown in red. The double-underlined base is the 
base mutated in promoter BKS106 to obtain promoter BKS107. 
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Figure 17. RNAP occupancies of promoters BKS106 and BKS107. 
These two bar charts show RNAP occupancies of BKS106 (upper chart) and 
BKS107 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS106 31.8 3.24 0.85% 65.4% 
BKS107 1479.6 100 27.2% 24.4% 
 
 -galactosidase levels, POI and EI values of promoters BKS106 
and BKS107. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS106 and BKS107 promoters. 
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PoPS was calculated for the two downstream regions lac1357 and lac2720 
depending on occupancies before and after rifampicin treatment as before. 
Occupancies of the promoter, lac1357 and lac2720 regions were 18, 4.4 and 6.6, 
respectively. Therefore, PoPS for the lac1357 region was calculated by first  
calculating the FOP, which yielded 6.64% (1/15 of the time occupied). Therefore, 
Tint for this region is 90 seconds (6 x 15). PoPS was calculated by dividing 1 by 
Tint, resulting in a value of 0.011. 
For the lac2720 region, the FOP was 10% (1/10 of the time occupied). Tint for 
this region was 60 seconds (6 x 10). Finally, PoPS was calculated by dividing 1 by 
Tint, yielding a PoPS of 0.017. These calculations can be seen in Table 27. 
 
4.8. Effect of improving -10 element on promoter 
activity 
The effect of having a consensus -10 element in the starting promoter BKS101 on 
promoter activity was also tested. The sequence of this element was altered by 
introducing a double mutation to bases -7 and -8, thereby changing the element 
sequence from 5’ TATGGT 3’ to the consensus sequence 5’ TATAAT 3’. Therefore, 
this altered promoter (BKS103) has a good -35, a good extended -10 and a 
consensus -10 hexamer as shown in Table 28. This change induced promoter 
activity as seen by reporter gene assay. The -galactosidase level increased from 
2322.3 in promoter BKS101 to 3608.1 with this promoter having a 
consensus -10 hexamer. The reporter gene assay results can be seen and 
compared in Figure 12. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS107 
18 - - - 
lac1357 4.4 6.64 90 0.011 
lac2720 6.6 10 60 0.017 
 
 PoPS for promoter BKS107. 
This table shows the occupancy value of each region and the for lac1357 and 
lac2720 regions of the BKS107 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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Promoter Sequence 
BKS101 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATGGTTATTTC 3’ 
BKS103 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATAATTATTTC 3’ 
 
 Sequences of promoters BKS101 and BKS103. 
This table shows the sequences of the BKS101 and BKS103 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the extended 
-10 elements are shown in green (bases -16 and -17) and yellow (bases -14 
and -15) and the -10 elements are shown in red. The double underlined bases 
are the bases mutated in the starting promoter to obtain the new promoter. 
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Promoter occupancy values obtained from the promoter region before and after 
rifampicin treatment using the ChIP-qPCR method also showed that the activity 
increased as a result of improving the -10 element of the promoter. Its full 
occupancy after rifampicin treatment increased from 61.1 units in promoter  
BKS101 to 83.9 units in this promoter giving 100% promoter competitivity. The 
measured promoter occupancy also increased from 25.7 units to 41.9 units as 
shown in Figure 18. POI slightly increased from 42.1% to 49.9% by having a 
consensus -10 element. However, the EI value decreased from 34.2% to 21%. 
These values are shown in Table 29. 
PoPS values for lac1357 and lac2720 downstream of this new promoter were 
also calculated using measured occupancies obtained from the ChIP-qPCR 
experiment. These occupancy values were 41.9, 8.8 and 4.3 units for the 
promoter, lac1357 and lac2720, respectively. PoPS was calculated for each 
region separately. For the lac1357 region, FOP was 10.5% (1/9.52 of the time 
occupied). Therefore, Tint for this region was 57.12 seconds (6 x 9.52). This leads 
to a PoPS value of 0.017 (1/57.12). Likewise, for the lac2720 region, FOP was 
5.1% (1/19.6 of the time occupied). Therefore, Tint for this region was 117.6 
seconds and the PoPS was 0.008 as shown in Table 30. 
 
4.9. Effect of having fully consensus promoter 
sequences on promoter activity 
To get a promoter containing consensus sequences in the -35, extended -10 an
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Figure 18. RNAP occupancies of promoters BKS101 and BKS103. 
These two bar charts show RNAP occupancies of BKS101  (upper chart) and 
BKS103 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS101 2322.342 100 42.1% 34.2% 
BKS103 3608.1 100 49.9% 21% 
 
 -galactosidase levels, POI and EI values of promoters BKS101 
and BKS103. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS101 and BKS103 promoters. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS103 
41.9 100 - - 
lac1357 8.8 10.5 57.12 0.017 
lac2720 4.3 5.1 117.6 0.008 
 
  PoPS for promoter BKS103. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS103 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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-10 elements, two single mutations (p34T and p16G) were introduced to the 
previously designed promoter BKS103. These two mutations aimed to provide 
the promoter with a consensus -35 element by changing base -34 from A to T 
and a consensus extended -10 element by changing base -16 from T to G. 
Therefore, the new promoter (BKS108) had a consensus -35 element sequence 
of 5’ TTGACA 3’, a consensus extended -10 element sequence of 5’ TGTG 3’ and a 
consensus -10 element sequence of 5’ TATAAT 3’ as shown in Table 31. 
When the -galactosidase level was assessed using reporter gene assay, this 
promoter showed a lower overall activity than promoter BKS103, even though 
all three elements consisted of consensus sequences. Specifically, the 
-galactosidase level decreased from 3608.1 units with promoter BKS103 to 
3263 units with this promoter. These findings are shown in Figure 12. 
However, this promoter showed higher promoter occupancy values than 
promoter BKS103 according to the ChIP-qPCR method. Promoter competitivity 
dramatically increased showing occupancy after rifampicin treatment of 294 
units, while it was 83.9 units for promoter BKS103 (both assumed as 100% 
occupancy). Similarly, the occupancy before rifampicin treatment also increased 
from 41.9 units with promoter BKS103 to 83.1 units with this consensus 
promoter (Figure 19). Occupancy values of the promoter and the lac1357 region 
were used to calculate promoter competitivity, POI and EI values for this 
promoter (Table 32). This promoter, with its consensus sequences, showed 
lower POI (28.26%) and EI (10.1%) values than promoter BKS103’s POI (49.9%) 
and EI (21%) values. 
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Promoter Sequence 
BKS103 GAATTCTAGACAGCTGCATGCATCTTTGTTATAATTATTTC 
BKS108 GAATTCTTGACAGCTGCATGCATCTGTGTTATAATTATTTC 
 
 Sequences of promoters BKS103 and BKS108. 
This table shows the sequences of the BKS103 and BKS108 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the extended 
-10 elements are shown in green (bases -16 and -17) and yellow (bases -14 
and -15) and the -10 elements are shown in red. The double-underlined bases 
are the bases mutated in promoter BKS103 to obtain the promoter BKS108. 
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Figure 19. RNAP occupancies of promoters BKS103 and BKS108. 
These two bar charts show RNAP occupancies of BKS103  (upper chart) and 
BKS108 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS103 3608.1 100 49.9% 21% 
BKS108 3263 100 28.26% 10.1% 
 
 -galactosidase levels, POI and EI values of promoters BKS103 
and BKS108. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS103 and BKS108 promoters. 
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Regarding PoPS calculations, the full occupancy state of the promoter and the 
measured occupancies of all regions were used. The FOP of lac1357 region was 
2.86% (1/35 of the time occupied). Therefore, this region was 1/35 of the time 
occupied by RNAP. Accordingly, Tint was calculated by multiplying the time taken 
by RNAP to traverse this region (6 seconds) by 35, which yielded 210 seconds. 
Consequently, the PoPS value was 0.0048 (1/210). Similarly, the FOP for the 
lac2720 region was 1.26% (1/79.4 of the time occupied). Therefore, Tint for this 
region was 476.4 seconds (6 x 79.4) meaning that a new RNAP arrives at the 
start of this region every 476.4 seconds. Therefore, PoPS was calculated by 
dividing 1 by 476.4, which yielded a value of 0.002. These calculated values are 
illustrated in Table 33. 
 
4.10. Effect of having a consensus -10 hexamer only on 
promoter activity 
The effect of having a consensus -10 hexamer only in a promoter was also tested 
by the new method developed in this study. The promoter (BKS109) was 
designed by changing 4 bases (-30 to -33) of the -35 element and one base (-14) 
of the extended -10 element of promoter BKS103. The activity of the -35 element 
was greatly reduced by changing its sequence from 5’ TAGACA 3’ (5/6 fit to the 
consensus) to 5’ TACTGT 3’ (1/6 fit to the consensus). The sequence of the 
extended -10 element was changed from 5’ TTTG 3’ to 5’ TTTT 3’ as shown in 
Table 34. After designing the promoter, promoter activity was primarily
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS108 
83.1 - - - 
lac1357 8.4 2.86 210 0.0048 
lac2720 3.7 1.26 476.4 0.002 
 
 PoPS for promoter BKS108. 
This table shows the occupancy value of each region and the FOP for lac1357 and 
lac2720 regions of the BKS108 promoter::lac fusion. It also shows the time 
interval between RNAPs crossing the lac1357 and lac2720 regions. All of these 
figures are necessary to calculate PoPS (also shown) for these two lacZ regions. 
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Promoter Sequence 
BKS103 5’ GAATTCTAGACAGCTGCATGCATCTTTGTTATAATTATTTC 3’ 
BKS109 5’ GAATTCTACTGTGCTGCATGCATCTTTTTTATAATTATTTC 3’  
 
  Sequences of promoters BKS103 and BKS109. 
This table shows the sequences of the BKS103 and BKS109 promoters (5’3’) 
from the EcoR1 site to base -1. The -35 elements are shown in blue, the extended 
-10 elements are shown in green (bases -16 and -17) and yellow (bases -14 
and -15) and the -10 elements are shown in red. The double-underlined bases 
are the bases mutated in promoter BKS103 to obtain BKS109 promoter. 
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assessed using the reporter gene assay to measure the -galactosidase level with 
this promoter. The -galactosidase level immensely declined from 3608.1 units 
with promoter BKS103 to 44.2 units with this promoter containing a consensus -
10 element only, as shown in Figure 12. 
After primary promoter activity assessment with the reporter gene assay, the 
ChIP-qPCR method was applied to gain a deeper perspective on how promoter 
activity had changed. The promoter showed lower RNAP recruitment activity by 
demonstrating lower occupancy values both before and after rifampicin 
treatment. Promoter occupancy after rifampicin treatment decreased from 83.9 
units to 20.5 units showing promoter competitivity of 24.4%. Similarly, the 
measured promoter occupancy before rifampicin treatment decreased from 41.9 
units to 3.2 units as shown in Figure 20. The POI of this promoter greatly 
decreased from 49.9% to 3.8% after altering the -35 and extended -10 promoter 
elements; however, the EI of this promoter slightly improved, increasing from 
21% with promoter BKS103 to 21.9% with this promoter, as shown in Table 35. 
PoPS values were also calculated for the lac1357 and lac2720 regions of the 
BKS109 promoter::lac fusion using occupancy values obtained from the 
ChIP-qPCR experiment. These occupancies were 3.2 units for the promoter 
region and 0.7 units for both the lac1357 and lac2720 regions. For both lacZ 
regions, the FOP was 0.83% (1/120.5 of the time occupied). Therefore, the Tint 
for both segments was 723 seconds (6 x 120.5). Finally, PoPS was calculated by 
dividing 1 by Tint resulting in a value of 0.0014 for both regions, as shown in 
Table 36. 
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Figure 20. RNAP occupancies of promoters BKS103 and BKS109. 
These two bar charts show RNAP occupancies of BKS103  (upper chart) and 
BKS109 (bottom chart) promoters and their lac1357 and lac2720 regions 
obtained from the ChIP-qPCR experiment. The blue bars show occupancies 
before rifampicin treatment and the red bars show occupancies after rifampicin 
treatment. All occupancies are the average of at least three biological repeats and 
three technical repeats. Error bars show the standard deviations of these 
calculated occupancies. 
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Promoter β-gal level Promoter 
competitivity 
(%) 
POI EI 
BKS103 3608.1 100 49.9% 21% 
BKS109 44.2 24.4 3.8% 21.9% 
 
  -galactosidase levels, POI and EI values of promoters 
BKS103 and BKS109. 
This table summarizes the measured -galactosidase levels and calculated 
promoter competitivity, POI and EI values of the BKS103 and BKS109 promoters. 
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Region 
Occupancy 
value (unit) 
FOP (%) 
Tint 
(seconds) 
PoPS 
Promoter     
BKS109 
3.2 - - - 
lac1357 0.7 0.83 723 0.0014 
lac2720 0.7 0.83 723 0.0014 
 
 PoPS for promoter BKS109. 
This table shows the occupancy values and the FOP lac1357 and lac2720 regions 
of the BKS109 promoter::lac fusion. It also shows the time interval between 
RNAPs crossing the lac1357 and lac2720 regions. All of these figures are 
necessary to calculate PoPS (also shown) for these two lacZ regions. 
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4.11. Discussion 
Promoters are components of the DNA that participate in controlling 
transcription specificity by recruiting RNAP for the transcription of specific 
genes. This specificity depends solely on four specific promoter hexamer 
sequence elements and their sequences: the -10, extended -10, -35 and UP 
elements. In this study, a new method was developed to directly measure 
promoter strength and correlate it to different combinations of promoter 
elements. This method was optimized by testing promoters with different 
combinations of elements that was inserted into pRW50 plasmid carried by E. 
coli. Although there are several promoter elements known to effect promoter 
strength, we concentrated on testing the effect of three of these elements: the -
10, extended -10 and -35 promoter elements. This effect was assessed by 
comparing the measured activities of two promoters at a time. 
The starting promoter, BKS101, was obtained from the work of Burr and 
colleagues (2000). This promoter has a favorable combination of promoter 
elements and showed a -galactosidase activity of 2322.3 units and a 100% 
promoter competitivity. The POI of this promoter was 42.1%, meaning that it 
recruits RNAPs to a fairly good extent. Looking at the EI of this promoter, it is 
clear that not all recruited RNAPs are escaping easily. In fact, only 34.2% of 
recruited RNAPs are escaping downstream to transcribe subsequent genes. 
These escaping RNAPs showed PoPS values of 0.024 and 0.014 for downstream 
regions lac1357 and lac2720 regions, respectively. In other words, this promoter 
is limited in terms of the escape level of RNAPs. These findings were aligned with 
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our expectations, as robust promoter-DNA interactions bind RNAPs tightly and 
do not let the RNAPs escape easily. 
Improving the extended -10 region of promoter BKS101 by changing the 
extended -10 sequence form 5’ TTTG 3’ to 5’ TGTG 3’ notably boosted overall 
promoter activity. There was an approximate 57% increase in -galactosidase 
levels, implying that the extended -10 element plays a vital role in transcription 
activity. However, the promoter competitivity was the same as in the original 
promoter BKS101 showing a value of 100%. Burr and colleagues (2000) tested 
the same mutation and recorded approximately the same increase in 
-galactosidase levels. Yielding a value of approximately 91%, POI increased by 
more than two-folds as well, suggesting that the promoter’s affinity to RNAPs has 
increased after improving the extended -10 element. Such a strong promoter will 
bind RNAPs very well and will not let them escape easily. The EI slightly 
increased by ~7% more than promoter BKS101 EI, meaning that this new 
promoter is also limited in terms of escape of RNAPs. However, considering the 
amount of recruited RNAPs, the escaping RNAPs showed higher PoPS values 
than PoPS values of the starting promoter BKS101 in both downstream regions. 
These values were 0.06 and 0.034 for lac1357 and lac2720 regions, respectively. 
The effect of demoting the extended -10 element of promoter BKS101 was also 
tested. The sequence of this element was changed from 5’ TTTG 3’ to 5’ TTTT 3’, 
and this change lowered promoter activity as measured by reporter gene assay 
and promoter full occupancy with rifampicin. -galactosidase levels decreased 
from 2322.3 units to approximately 31.8 units and the full occupancy state 
dropped from 61.1 units to approximately 2 units showing a 3.24 promoter 
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competitivity. The POI dropped to 0.85% only. However, the EI showed almost a 
two-fold increase from 34.2% to 65.4%. These results show that knocking down 
the extended -10 element severely impairs the promoter’s ability to recruit and 
hold RNAPs. However, there was a very long time gap between RNAPs passing 
through downstream regions. For lac1357, Tint was around 18 minutes resulting 
in a PoPS value of 0.0009 and for lac2720, Tint was around 30 minutes giving a 
PoPS value of 0.0005. The same combination of promoter elements was tested by 
Burr and colleagues (2000) and showed the same diminishing promoter activity. 
Conversely, giving promoter BKS101 a perfect -35 element did not increase 
promoter activity. Instead, the overall activity decreased dramatically, yielding a 
-galactosidase level of only 64.85 units. The promoter competitivity greatly 
decreased to 6.92, as well. POI greatly decreased from 42.1% in promoter 
BKS101 to 3.86% in this promoter. However, EI value was slightly higher than 
promoter BKS101 showing a value of 45.8%, which means the promoter is still 
limited in terms of escape similar to promoter BKS101. The amount of RNAPs 
escaping the promoter showed PoPS values lower than promoter BKS101. The 
Tint for lac1357 and lac2720 regions were around 5.5 and 6.5 minutes and 
yielded PoPS values of 0.003 and 0.0026, respectively. These findings were in 
accordance with expectations and supported the findings of previous studies. A 
study carried out by Ellinger and colleagues (1994) confirmed that promoters 
containing elements with consensus sequences exhibited RNAP stalling in the +6 
to +12 region followed by slow release from this state. Monsalve and colleagues 
(1997) studied transcription repression by phage Φ29 protein p4 and revealed 
that this repression occurs in the presence of the -35 element of the promoter; 
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furthermore, removing this element leads to transcription activation. This same 
finding was also presented in another study conducted by Hsu (2002). The 
results of these three studies support the notion that repression results from the 
stalling of RNAP at the promoter, which is caused by the strong promoter-DNA 
interactions of consensus promoter elements. 
The effect of weakening the promoter -10 element was also tested in this study. 
A promoter containing the same sequence as BKS101 with a single mutation to 
the -10 element was used (BKS105). This promoter was designed by Chan and 
Busby (1989) as a control in their study. The researchers found that changing 
the -12 base of the -10 element from T to C lowered promoter activity by more 
than 50-fold. We assessed the same activity by reporter gene assay and found 
that -galactosidase levels drastically decreased by around 77-fold to only 
approximately 30.05 units. Even more interestingly, promoter competitivity 
decreased to only 12.4%. POI dropped to around 1.52%, demonstrating that 
the -10 element plays a decisive role in recruiting RNAPs (i.e., the weaker the -10 
element, the fewer RNAPs are recruited). On the contrary, EI dramatically 
increased to approximately 86% and almost all recruited RNAPs escaped easily. 
This implies that demoting the -10 element significantly facilitated open complex 
formation and, accordingly, RNAP escape, resulting in a promoter that is limited 
at the recruitment step. This increased level of promoter escape resulted in a Tint 
of around 7.7 minutes and a PoPS value of 0.0022 in lac1357 region. For lac2720 
region, the Tint was around 9.5 minutes resulting in a PoPS of 0.0017. 
To test the effect of downgrading the extended -10 element, the ChIP-qPCR 
method was applied to another promoter (BKS107), which was obtained from 
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Chan and busby (1989). This promoter differs from promoter BKS101 at 
bases -14 and -34 of the extended -10 and -35 elements, respectively. The 
sequence of the extended -10 element was 5’ TTTT 3’ instead of 5’ TTTG 3’ in 
promoter BKS101, while the -35 element contains a consensus sequence of 
5’ TTGACA 3’. Demoting the extended -10 element alone, in promoter BKS106 
tested previously, decreased promoter activity. Nevertheless, combining this 
demotion with a perfect consensus -35 element revived promoter activity to 
some extent. Reporter gene assay for this new promoter showed a 
-galactosidase level of 1479.6 units, which is higher than the promoter with a 
demoted extended -10 element only (BKS106). The full occupancy increased as 
well, to approximately 66 units showing a 100% competitive promoter. POI and 
EI were calculable and reached 27.2% and 24.4%, respectively, which are still 
lower than those of promoter BKS101 that has a good extended -10 element 
(5’ TTTG 3’). However, by comparing POI and EI values of this promoter to the 
promoter BKS106 that has the same sequence with a mutated -35 element 
(shown above), the POI greatly increased from 0.85% in promoter BKS106 to 
27.2% in this promoter. The EI value decreased with the new promoter, 
containing a consensus -35 element sequence, from 65.4% with promoter 
BKS106 to 24.4% with this promoter; this supports the idea that increasing 
promoter-DNA interactions with consensus sequences stalls RNAP at promoters 
and makes promoter escape slower and more difficult. This new promoter 
showed Tint values of around 1.5 and 1 minutes and PoPS values of 0.011 and 
0.017 for lac1357 and lac2720, respectively. PoPS for lac2720 was slightly higher 
than in lac1357 of the same promoter, which might be as a result of RNAP 
bursting. 
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Two of the designed promoters, apart from the fully consensus promoter 
BKS108, contained a consensus -35 element, which are BKS104 and BKS107. In 
promoter BKS104, this consensus element was combined with a good 
extended -10 element (5’ TTTG 3’). Whereas, in promoter BKS107, this 
consensus -35 element was combined with a weak extended -10 element 
(5’ TTTT 3’). Surprisingly, promoter activity was extremely less in promoter 
BKS104 than promoter BKS107. Furthermore, the consensus -35 element, when 
combined with a good extended -10 element in promoter BKS104, showed more 
Tint and less PoPS levels than when it was combined with a weak extended -10 
element in promoter BKS107. 
Unlike BKS105, which has the same elements as promoter BKS101 with the -10 
element demoted, the BKS103 promoter has been designed to have the same 
sequence with the -10 element improved to a consensus sequence 
(5’ TATAAT 3’). This mutation positively affected -galactosidase level, full 
occupancy state and POI for this new promoter. This promoter showed a 100% 
competitivity, a -galactosidase level of 3608.1, a POI of 49.9% and an EI of 21%. 
Improving the -10 element of the promoter enhanced its ability to recruit RNAP 
but lowered RNAP escape rate. This decreased escape rate resulted in more Tint 
levels and less PoPS levels in downstream regions. The fact that improving 
the -10 element lowered the RNAP escape rate confirms that improving 
promoter sequence with consensus sequences increases the affinity of the 
promoter to RNAP and reduces the opportunity for RNAP escape. 
As demonstrated previously, the perfect promoter with consensus sequences in 
all elements has lower -galactosidase level, POI and EI than promoters BKS102 
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and BKS103. Essentially, this promoter showed the lowest EI among all tested 
promoters. The lower -galactosidase level and EI are understandable, because 
the promoter has a very high affinity to RNAP and binds it very tightly; this 
negatively affects the escape rate and, consequently, the transcription rate. The 
fact that this consensus promoter recorded the highest occupancy after 
rifampicin treatment among all tested promoters is noteworthy. However, even 
though promoter occupancy under normal conditions was higher than all tested 
promoters, the POI value was lower than promoters BKS101, BKS102 and 
BKS103. The same consensus promoter was tested in a previous study 
conducted by Vo and colleagues (2003). They confirmed that consensus 
promoters recruit RNAPs but bind them more tightly than usual, leading to 
higher abortive initiation. 
Improving the -10 element only, without good -35 and extended -10 elements in 
promoter BKS109, did not increase the promoter activity. The -galactosidase 
level was very low according to reporter gene assay. Full promoter occupancy 
with rifampicin declined drastically, showing promoter competitivity of 24.4%, 
and indicated that this promoter was not recruiting RNAPs effectively. The low 
POI of 3.8% further indicates that the promoter is not recruiting RNAPs 
efficiently in normal conditions. The low EI of 21.9% shows that recruited 
RNAPs, although they are very few in number, are not escaping easily. Therefore, 
the -10 element cannot initiate successful transcription without the help of 
the -35 and extended -10 elements. 
All figures obtained for different promoters and their downstream elements are 
shown in Table 37. For the promoter region, these figures include 
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-galactosidase activity, promoter competitivity, POI and EI. While, for the 
downstream regions lac1357 and lac2720, these figures include FOP, Tint and 
PoPS  
The new method developed in this study provides sound and direct insight on 
how promoter elements affect transcription activity. Generally, the closer the 
element to the consensus sequence, the more active the promoter. However, 
providing a promoter with consensus -35, extended -10 and -10 elements will 
increase the promoter’s affinity to RNAPs and lower the chance of successful 
transcription. The promoter will hold RNAPs tightly, which makes RNAP escape 
very difficult. Moreover, initiating successful transcription is a collaborative task, 
which means that no matter how strong is the element; it cannot begin 
transcription without the help of other elements 
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 Summary of calculated parameters for all promoters used in this study. 
This table summarizes all calculated parameters for all semisynthetic promoters used in this study. It shows -galactosidase levels, 
POI and EI for each promoter. It also illustrates FOP, Tint and PoPS values for the two tested downstream regions the of lacZ gene 
following each promoter. 
 
 
    
Promoter 
-gal Promoter 
competitivity 
(%) 
POI 
(%) 
EI 
(%) 
FOP (%) 
(lac1357) 
Tint (sec) 
(lac1357) 
PoPS 
(lac1357) 
FOP (%) 
(lac2720) 
Tint (sec) 
(lac2720) 
PoPS 
(lac2720) 
BKS101 2322.3 100 42.1 34.2 14.4 41.6 0.024 8.5 70.6 0.014 
BKS102 4063.3 100 91.3 41.1 37.5 16 0.06 20.7 29 0.034 
BKS103 3608.1 100 49.9 21 10.5 57.12 0.017 5.1 117.6 0.008 
BKS104 64.85 6.92 3.86 45.8 1.8 333.3 0.003 1.54 389.4 0.0026 
BKS105 30.05 12.4 1.52 86 1.3 461.4 0.0022 1.05 571.2 0.0017 
BKS106 31.8 3.24 0.85 65.4 0.56 1071.6 0.0009 0.33 1818 0.0005 
BKS107 1479.6 100 27.2 24.4 6.64 90 0.011 9.95 60 0.017 
BKS108 3263 100 28.26 10.1 2.86 210 0.0048 1.26 476.4 0.0021 
BKS109 44.2 24.4 3.8 21.9 0.83 723 0.0014 0.83 723 0.0014 
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Chapter 5 
Final Discussion 
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It has been well established that the gene expression pattern of any bacterium depends 
on different environmental conditions that consequently affect the number of RNAPs 
transcribing different bacterial genes. While these differences have been observed with 
different laboratory techniques, such as reporter gene assays, most of these techniques 
rely on estimating the gene product, which indirectly measures gene activity. In this 
study, a new simple and direct method, consisting of ChIP followed by qPCR, was 
developed to offer a direct insight into RNAP behavior in vivo at any selected DNA 
fragment. This technique works simply by crosslinking RNAP to DNA, which is then 
sheared by sonication and pulled down using specific beads and antibodies against 
RNAP. These immunoprecipitated DNA fragments are then quantified by qPCR using 
specifically designed probes to quantify only DNA fragments of interest. Exploiting the 
ability of rifampicin to block RNAPs at promoters allowed the calculation of promoter 
occupancy index (POI) and promoter competitivity. Quantifying immunoprecipitated 
DNA fragments of the same lengths allowed the calculation of EI (Escape Index) and 
RNAP flux through downstream transcription units. Two aspects of RNAP flux, through 
transcription units, were calculated: time interval between RNAPs coming to a specific 
single point of the transcribed fragment (Tint) and, subsequently, how many RNAPs pass 
through this point every second (Polymerase per Second; PoPS). Knowing the Tint 
allowed for the calculation of PoPS for each fragment of interest. These calculations 
were mainly dependent on the lengths of DNA fragments and how fast RNAP traverses 
these fragments. In present study, some of the calculated parameters, which are 
percentage of measured fragment occupancy to measured promoter occupancy; and Tint, 
were used to calculate PoPS for downstream fragments. However, there are some other 
derived parameters, which are promoter competitivity, POI, EI and FOP, which were 
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used to compare promoter strengths after manipulating the sequences of the promoter 
different elements to address the effect of introducing particular mutations on general 
promoter strength. 
In a previous study, PoPS was calculated indirectly for different promoters under 
specific conditions (Kelly et al., 2009). At the time of that study and to the researcher’s 
best knowledge, there were no direct in vivo methods to measure PoPS. However, the 
researchers measured PoPS, indirectly for their promoters by fusing them to GFP coding 
genes. The amount of synthesized GFP can reflect promoter activity and be used to 
calculate PoPS using a specific quantitative model. Interestingly, Kelly and colleagues 
found that transcribing RNAPs are separated and in some of their promoters they 
reported PoPS values of 0.03 and 0.015, which are very similar to our findings using the 
developed direct method on the lac operon. Recently, Nielsen and colleagues (2016) 
designed genetic circuits with known functions using computational approaches. These 
circuits were then inserted into different genetic positions and transformed into specific 
bacterial strains. The researchers used one of the promoters as a standard with an 
output value of 1 relative promoter unit (RPU), which was then measured and found to 
be approximately 0.02 PoPS per promoter. This figure is in the same window of PoPS 
values measured in the present study using my direct method.  
Although my developed technique is direct and provides a good in vivo perspective on 
the transcription process, it also has disadvantages. One of the major drawbacks of the 
method is that it is a blunt tool and might not be terribly accurate, especially when 
promoter activity goes really low and close to the background signal. In addition to this, 
it is an “ensemble” measurement, and ignores stochasticity between cells (i.e., it does not 
analyze single RNAP molecules). Another disadvantage of this method derives from the 
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significant background signals, which make the technique more plausible with strong 
promoters than weak ones; weak promoters cannot compete with strong ones in 
recruiting RNAPs even after rifampicin treatment. The final drawback is the result of the 
pause sequences, which are not detectable and highly affect the parameters measured 
with this technique, such as Tint and PoPS. The high background levels and the pause 
sequences issues can be precluded by a technique, that was developed by Churchman 
and Weissman (2011) whilst I have been doing my work, known as the nascent 
elongating template sequencing (NET-seq). This method was also used by Larson and 
his colleagues to identify a consensus pause sequence responsible for over 20,000 
regulatory pause sites in E. coli (Larson et al., 2014). 
The calculated POI, EI, Tint and PoPS of transcription units having promoters with 
different combinations of elements revealed that changing promoter elements have a 
non-negligible effect on promoter ability to recruit RNAPs and on RNAP escape 
efficiency. While some promoter elements are more involved in RNAP recruitment, the 
same elements can affect RNAP escape rate and vice versa. Promoter strength can 
consequently affect the transcription of downstream genes by decreasing or increasing 
the RNAP supply to these genes. 
Calculating the same parameters of the lac operon on the chromosome, surprisingly, 
showed that transcribing RNAPs are well separated along the lac operon by at least 9.6 
seconds in the lac3 DNA fragment. Accordingly, recalling that RNAP crosses ~50 bases 
each second, RNAPs in this region will be separated by ~480 bases. In the lac5 fragment, 
RNAPs were separated by ~51 seconds, which indicates that they are separated by 
~2550 bases. This unexpected finding has raised the question of why RNAPs are well 
separated during transcription of the lac operon. One possible reason is that, during 
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transcription elongation, RNAP causes local topological changes to the DNA by 
introducing negative supercoils behind and positive supercoils ahead (Liu and Wang, 
1987); this may lead to limited access to the gene being transcribed for the following 
RNAPs, resulting in the noted gap between RNAPs. Transcriptional pausing is another 
possible cause of this separation between RNAPs. As has been noted in a previous study, 
RNAP pausing because of backtracking results in an extended elongation time (Voliotis 
et al., 2008). This represents a logical concept, as RNAP involved in backtracking will be 
delayed for some time and the distance to the RNAP ahead will increase. Interestingly, 
regardless of the differences in PoPS values, PoPS values calculated in linear DNA and on 
the plasmid are so close to each other showing that transcribing RNAPs are well 
separated on both types of DNA. 
The direct method developed in the present study is of a beneficial use in synthetic 
biology, as it can be used to establish a standardized hierarchy of core promoters based 
on the number of polymerase molecules passing through the gene per second (i.e., 
PoPS). This hierarchy can be built by correlating the ability of RNAP to transcribe a gene 
with the strength of core promoter, which is achievable by counting the number of 
RNAP enzymes traveling through a gene that are inhibited at different strengths of core 
promoters. This information can be utilized in synthetic biology systems where precise 
amounts of gene expression can be tailored to fit specific applications. 
This developed direct method can contribute to the improvement of engineering 
biological parts and consequently the improvement of synthetic biology. This 
contribution could potentially result from obtaining previously estimated final products 
of constructed genes and the ability to understand RNAP distribution through a given 
gene. The idea of building biological parts was proposed by Knight and colleagues 
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(2003) in an attempt to improve engineering mechanisms for assembling constructed 
biological components into cellular systems. These biological parts are used as 
“biobricks” to build larger systems with known functions to be incorporated into 
organisms, such as bacteria. 
The present study provides substantial information about the RNAP behavior at certain 
DNA sequences by measuring RNAP recruitment and flux directly instead of measuring 
final gene products. However, to gain a holistic understanding of the transcription 
system, many other methods can be applied to enhance knowledge of different aspects 
of this work and to confirm its findings. These methods include the following: electron 
tomography (ET); cell modelling, such as virtual electronic cell (e-cell); high-resolution 
imaging, such as photo-activated localisation microscopy (PALM) and high-throughput 
sequencing. 
ET can be used to confirm my findings by creating a three-dimensional structure of the 
cellular contents. If possible, ET will allow the visualisation of bacterial DNA and all 
DNA-attached proteins including RNAPs, which will be beneficial in the study of all the 
parameters calculated in the present research for any given gene and RNAP distribution 
along the DNA. In an ideal experiment, it may be possible to follow populations in time 
as well. A study involving virtual cell modeling using computations, mathematical 
modeling and simulations of transcription would produce a model of RNAP recruitment, 
open promoter complex formation, RNAP escape and PoPS. Such a study would be of use 
for validating the findings of the present study by clarifying the differential access of 
RNAP to certain genes in relation to its location on the chromosome. Using tomographic 
techniques like photo activated-localisation microscopy (PALM), cryo-electron 
microscopy and single-molecule tracking by RNAP tagging can be used to visualize 
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RNAPs. This approach will validate the results of the present study and overcome the 
study’s drawbacks, such as an inability to visualize RNAP bursting, DNA scrunching and 
stalled RNAPs. Applying the direct method developed in the present study on a large 
population of different promoters and using different host cells can verify RNAP 
recruitment, escape and flux in virtual cell models as well. High-throughput sequencing 
could also assist in confirming my findings by sequencing RNA chains produced by the 
constructed biobricks. This approach would provide beneficial, high-resolution 
information about pause sequences that essentially affect RNAP flux through 
transcription units (Larson et al., 2014). These aforementioned research projects were 
beyond the scope of present study, but may be important in further elucidating the 
processes that were researched. 
The wider conclusion of this study is that the density of RNAP, on both the plasmid and 
the chromosome, is a lot less than we think. What is more interesting is that PoPS values 
on the plasmid and on the chromosome are roughly the same. The direct method 
proposed in this study has a potential to directly measure RNAP density on any gene 
other than the lac operon. It also has a potential in situations other than studying RNAP 
density on the lac operon performed in present study. This method is also has a 
potential for use in any coding region. 
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